geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 53029

Chapter 53029 provides bibliographic information on scholary research in geography and in the life sciences.



Erythrodermic atopic dermatitis with late onset--case presentation. Journal of Medicine and Life 3(1): 80-83

Erythrodermic crusted scabies induced by corticosteroids treated with ivermectin. A case report. Revista Espanola de Geriatria Y Gerontologia 46(3): 174-175

Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis. International Journal of Dermatology 46(11): 1198-1204

Erythrodermic juvenile dermatomyositis. Pediatric Dermatology 26(2): 234-235

Erythrodermic lichen planus. Dermatology Online Journal 17(10): 26-26

Erythrodermic lymphomatoid granulomatosis: a case report. Case Reports in Dermatology 3(3): 244-250

Erythrodermic mycosis fungoides with hypereosinophilic syndrome: a rare presentation. Ecancermedicalscience 7: 337-337

Erythrodermic psoriasis. Qjm 107(4): 315-315

Erythrodermic psoriasis complicated by acute respiratory distress syndrome. European Journal of Dermatology 21(3): 429-430

Erythrodermic psoriasis improved by panitumumab, but not bevacizumab. Acta Dermato-Venereologica 92(4): 360-361

Erythrodermic psoriasis successfully treated with efalizumab. European Journal of Dermatology 18(3): 357-358

Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin. Diagnostic Pathology 9(): 102-102

Erythrodermic psoriasis with regression after prophylaxis with isoniazid and antidepressant therapy: case report. Anais Brasileiros de Dermatologia 86(4 Suppl 1): S141-S143

Erythrodermic psoriasis: epidemiological clinical and therapeutic features about 60 cases. La Tunisie Medicale 89(11): 841-847

Erythrodermic pustular psoriasis triggered by intravesical bacillus Calmette-Guérin immunotherapy. Clinical and Experimental Dermatology 37(4): 455-457

Erythrodermic verrucous psoriasis. Journal of Dermatological Treatment 23(3): 215-218

Erythrodextrin In Maize. Science 57(1480): 556-557

Erythrodiol, a natural triterpenoid from olives, has antiproliferative and apoptotic activity in HT-29 human adenocarcinoma cells. Molecular Nutrition & Food Research 52(5): 595-599

Erythrodontia in congenital erythropoietic porphyria. Journal of Oral and Maxillofacial Pathology 15(1): 69-73

Erythroexchange in sickle cell disease. A three-step procedure to remove more haemoglobin S. Blood Transfusion 13(2): 340-341

Erythroferrone contributes to recovery from anemia of inflammation. Blood 124(16): 2569-2574

Erythroferrone, an erythroid regulator of iron metabolism. Medecine Sciences 30(10): 834-836

Erythroid 5-aminolevulinate synthase mediates the upregulation of membrane band 3 protein expression by iron. Cell Biochemistry and Function 28(2): 122-125

Erythroid DAMPs drive inflammation in SCD. Blood 123(24): 3689-3690

Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Research 19(12): 2172-2184

Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activator and is required for gamma-globin gene induction by short-chain fatty acid derivatives. European Journal of Haematology 82(6): 466-476

Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfusion Clinique et Biologique 15(1-2): 39-50

Erythroid and megakaryocytic differentiation of K562 erythroleukemic cells by monochloramine. Free Radical Research 48(3): 292-302

Erythroid but not cytogenetic response in a case with 5q- syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?. Leukemia & Lymphoma 55(6): 1408-1409

Erythroid cells generated in the absence of specific β1-integrin heterodimers accumulate reactive oxygen species at homeostasis and are unable to mount effective antioxidant defenses. Haematologica 98(11): 1769-1777

Erythroid cells in vitro: from developmental biology to blood transfusion products. Current Opinion in Hematology 16(4): 259-268

Erythroid crisis caused by parvovirus B19 transmitted via red blood cell transfusion. Internal Medicine 50(20): 2379-2382

Erythroid defects in TRalpha-/- mice. Blood 111(6): 3245-3248

Erythroid differentiation is augmented in Reelin-deficient K562 cells and homozygous reeler mice. Febs Letters 588(1): 58-64

Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin. Haematologica 100(1): 32-41

Erythroid differentiation-associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis. Febs Journal 279(16): 2848-2862

Erythroid diseases: focusing on MDS. Overview. Japanese Journal of Clinical Hematology 54(1): 3-4

Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study. American Journal of Clinical Dermatology 13(1): 37-47

Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction. Blood 114(19): 4045-4053

Erythroid expansion and survival in response to acute anemia stress: the role of EPO receptor, GATA-1, Bcl-xL and caspase-3. Cell Biology International 32(8): 966-978

Erythroid glucose transporters. Current Opinion in Hematology 16(3): 165-172

Erythroid heme biosynthesis and its disorders. Cold Spring Harbor Perspectives in Medicine 3(4): A011676-A011676

Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with a photoproduct derived from the UV-A irradiation of 5-methoxypsoralen. Chemmedchem 5(9): 1506-1512

Erythroid karyorrhexis in myelodysplasia: bone marrow aspirate. Blood 112(3): 479-479

Erythroid leukemia evolving from multiple myeloma. Blood 119(11): 2441-2441

Erythroid mRNA processing: a "splice of life". Blood 124(4): 474-475

Erythroid maturation and proliferation arrest: the GATA-1 connection: comment on: Papetti M. Cell cycle 2010; 9:1972-80. Cell Cycle 9(10): 1877-1877

Erythroid nuclear irregularities: a review of fetal and neonatal autopsies and correlation with clinical features. Annals of Clinical and Laboratory Science 44(1): 10-18

Erythroid phenotypes associated with KLF1 mutations. Haematologica 96(5): 635-638

Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence. Plos One 5(3): E9496-E9496

Erythroid promoter confines FGF2 expression to the marrow after hematopoietic stem cell gene therapy and leads to enhanced endosteal bone formation. Plos One 7(5): E37569-E37569

Erythroid recovery affects tacrolimus levels after engraftment during stem cell transplantation. Biological & Pharmaceutical Bulletin 35(10): 1648-1654

Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes. Leukemia Research 35(4): 504-507

Erythroid-extrinsic regulation of normal erythropoiesis by retinoic acid receptors. British Journal of Haematology 164(2): 280-285

Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation. Experimental Hematology 36(9): 1205-1215

Erythroid-specific expression of β-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells. Plos One 6(12): E29110-E29110

Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients. Plos One 7(4): E34951-E34951

Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms. Journal of Clinical Oncology 27(25): 4217-4226

Erythroidine alkaloids: a novel class of phytoestrogens. Planta Medica 80(11): 861-869

Erythrokeratoderma variabilis responding to low-dose isotretinoin. Pediatric Dermatology 27(1): 111-113

Erythrokeratodermia progressivum symmetricum. Indian Journal of Dermatology, Venereology and Leprology 64(3): 126-127

Erythrokeratodermia variabilis. Annales de Dermatologie et de Venereologie 140(2): 129-133

Erythrokeratodermia variabilis - variant with circumscribed variable erythema and periorificial fixed Bazex Dupré erythema. Romanian Journal of Morphology and Embryology 48(4): 443-447

Erythrokeratodermia variabilis: first Japanese case documenting GJB3 mutation. Journal of Dermatology 40(5): 402-403

Erythrokeratodermia variabilis: report of two cases and a novel missense variant in GJB4 encoding connexin 30.3. European Journal of Dermatology 22(2): 182-186

Erythrokeratodermia variabilis: successful palliative treatment with acitretin. Indian Journal of Dermatology, Venereology and Leprology 74(6): 649-650

Erythrokeratodermia variabilis: successful treatment with retinoid plus psoralen and ultraviolet A therapy. Journal of Dermatology 38(7): 725-727

Erythrokinetics Of Miniature Swine Ingesting Sr-90. Hw-76000. Hw-Sa Reports . U.S. Atomic Energy Commission 86: 89-92

Erythrokinetics and ferrokinetics. Importance of their investigation in the pathogenetic and functional diagnosis of anemias. Progresos de Patologia Y Clinica 9: 7-24

Erythroleukaemia at second glance. European Journal of Haematology 86(4): 358-359

Erythroleukemia - a subtype of myelodysplastic syndrome?. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15(2): 219-223

Erythroleukemia Presenting as Non-immune Haemolytic Anemia: A Rare Presentation. Indian Journal of Hematology & Blood Transfusion 30(Suppl 1): 219-222

Erythroleukemia in a retrovirus-negative cat. Journal of the American Veterinary Medical Association 240(3): 294-297

Erythroleukemia presenting with myeloid sarcoma of the lung as detected by immunophenotypic analysis of bronchoalveolar lavage fluid. Leukemia Research 36(3): E46-E49

Erythroleukemia relapsing as precursor B-cell lymphoblastic leukemia. Korean Journal of Laboratory Medicine 31(2): 81-85

Erythroleukemia showing early erythroid and cytogenetic responses to azacitidine therapy. Annals of Hematology 92(5): 707-709

Erythroleukemic blast crisis of chronic myeloid leukemia.. Korean Journal of Laboratory Medicine 26(4): 255-262

Erythrolic acids A-E, meroterpenoids from a marine-derived Erythrobacter sp. Journal of Organic Chemistry 77(7): 3401-3407

Erythromelagia: a rare and hard-to-treat condition: a 9-year-old boy responsive to intravenous lidocaine and oral mexilitene. Pain Medicine 14(2): 311-312

Erythromelalgia Consequent to Hemiplegia : With Report of a Case. Journal of the National Medical Association 24(1): 19-24

Erythromelalgia Secondary to Arterio-sclerosis. Proceedings of the Royal Society of Medicine 21(2): 271-272

Erythromelalgia accompanying rosuvastatin-associated myopathy. Journal of Dermatological Case Reports 3(1): 1-3

Erythromelalgia and Raynaud's Disease. Proceedings of the Royal Society of Medicine 9(Dermatol Sect): 15-15

Erythromelalgia and livedo reticularis in a patient with essential thrombocythemia, acquired von Willebrand disease, and elevated anti-phospholipid antibodies. Annals of Dermatology 24(2): 214-217

Erythromelalgia associated with Clitocybe acromelalga intoxication. Clinical Toxicology 51(5): 451-454

Erythromelalgia in One Lower Limb. Proceedings of the Royal Society of Medicine 43(6): 479-479

Erythromelalgia in a diabetic patient managed with gabapentin. Diabetes Research and Clinical Practice 79(3): E15-E16

Erythromelalgia mutation L823R shifts activation and inactivation of threshold sodium channel Nav1.7 to hyperpolarized potentials. Biochemical and Biophysical Research Communications 390(2): 319-324

Erythromelalgia of the ears: an unusual variant and response to therapy. Journal of Drugs in Dermatology 7(3): 285-287

Erythromelalgia presenting after neurosurgical intervention in a patient with multiple malformations of the spinal cord. Journal of the American Academy of Dermatology 65(4): E120-E122

Erythromelalgia presenting with premature exfoliation of primary teeth: a diagnostic dilemma. Pediatric Dentistry 34(5): 422-426

Erythromelalgia responding to aspirin. Indian Journal of Dermatology, Venereology and Leprology 62(3): 204-205

Erythromelalgia-like Symptoms with High Blood-pressure. Proceedings of the Royal Society of Medicine 25(4): 403-404

Erythromelalgia: Incidence and clinical experience in a single centre in Sweden. Vasa. Zeitschrift für Gefasskrankheiten 41(1): 43-48

Erythromelalgia: a novel postoperative complication. Foot & Ankle International 31(3): 264-266

Erythromelalgia: a rare microvascular disease. Journal of Vascular Nursing 28(2): 67-71

Erythromelalgia: an uncommon presentation precipitated by aspirin withdrawal. Case Reports in Medicine 2012: 616125-616125

Erythromelalgia: two case reports and literature review. Polskie Archiwum Medycyny Wewnetrznej 117(7): 322-326

Erythromelanosis follicularis faciei et colli: case reports of bilateral lesions in 2 females. Cutis 79(6): 459-461

Erythromelanosis follicularis faciei et colli: relationship with keratosis pilaris. Indian Journal of Dermatology, Venereology and Leprology 74(1): 47-49

Erythromycin A dimethyl sulfoxide disolvate 1.43-hydrate. Acta Crystallographica. Section E, Structure Reports Online 68(Pt 3): O700-O701

Erythromycin Estolate (Ilosone) and Jaundice. Canadian Medical Association Journal 88(23): 1173-1173

Erythromycin [Abstract. Proceedings of the Royal Society of Medicine 46(7): 531-531

Erythromycin ameliorates cigarette-smoke-induced emphysema and inflammation in rats. Translational Research 159(6): 464-472

Erythromycin and cycloheximide sensitivities of protein and RNA Synthesis in sporulating cells of Saccharomyces cerevisiae: Environmentally induced modifications controlled by chromosomal and mitochondrial genes. Current Genetics 4(1): 51-62

Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases. New Microbiologica 34(2): 187-193

Erythromycin as a prokinetic agent in newborns--useful or doubtful. Commentary on Y. Mansi et al.: Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants (Neonatology 2011;100:290-294). Neonatology 100(3): 297-298

Erythromycin as a prokinetic agent: risk factors. Journal of Visceral Surgery 147(2): E13-E18

Erythromycin as a prokinetic: is the overall benefit corroborated?. Critical Care Medicine 35(5): 1446; Author Reply 1446-7

Erythromycin as an alternative to reduce interfering extra-cardiac activity in myocardial perfusion imaging. Cardiovascular Journal of Africa 21(3): 142-147

Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14. Respirology 13(2): 215-220

Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology From Bed to Bench 6(4): 195-201

Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPbeta. Proceedings of the National Academy of Sciences of the United States of America 105(34): 12509-12514

Erythromycin effects on apoptosis of epithelial cell in nasal polyps. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 21(2): 84-85

Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation. Mediators of Inflammation 2012: 410232-410232

Erythromycin enhances abomasal emptying in healthy unweaned lambs as shown by acetaminophen absorption test. Journal of Veterinary Pharmacology and Therapeutics 35(4): 410-412

Erythromycin establishes early oral feeding in neonates operated for congenital intestinal atresias. Pediatric Surgery International 25(4): 361-364

Erythromycin ethylsuccinate obtaining possibilities. Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 112(4): 1104-1109

Erythromycin for GI motility; sunscreens; enoxaparin in obesity. Jaapa 24(8): 16-16

Erythromycin for improving enteral nutrition tolerance in adult critical patients: a systematic review and meta-analysis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26(6): 425-430

Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. Cochrane Database of Systematic Reviews (): Cd001815-Cd001815

Erythromycin for the treatment of feeding intolerance in preterm infants. Pediatrics and Neonatology 53(1): 2-3

Erythromycin improves gastric emptying half-time in adult cystic fibrosis patients with gastroparesis. Journal of Cystic Fibrosis 8(3): 193-197

Erythromycin in therapy of cyclic vomiting syndrome. Srpski Arhiv Za Celokupno Lekarstvo 135(5-6): 339-341

Erythromycin in whooping cough. Bmj 338: B2615-B2615

Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine 57(6): 582-589

Erythromycin inhibited glycinergic inputs to gastric vagal motoneurons in brainstem slices of newborn rats. Neurogastroenterology and Motility 22(11): 1232-1239

Erythromycin is preferable to metoclopramide as a prokinetic in acute upper GI bleeding. Gastrointestinal Endoscopy 74(1): 234; Author Reply 234-5

Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study. Bmc Gastroenterology 8(): 38-38

Erythromycin pretreatment induces tolerance against focal cerebral ischemia through up-regulation of nNOS but not down-regulation of HIF-1α in rats. Neurological Sciences 35(5): 687-693

Erythromycin prevents the pulmonary inflammation induced by exposure to cigarette smoke. Translational Research 158(1): 30-37

Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scandinavian Journal of Gastroenterology 46(7-8): 920-924

Erythromycin resistance and virulence genes in Enterococcus faecalis from swine in China. New Microbiologica 34(1): 73-80

Erythromycin resistance features and biofilm formation affected by subinhibitory erythromycin in clinical isolates of Staphylococcus epidermidis. Journal of Microbiology, Immunology, and Infection 49(1): 33-40

Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region. Infection 37(4): 353-357

Erythromycin restores oxidative stress-induced corticosteroid responsiveness of human THP-1 cells by up-regulating the expression of histone deacetylase 2. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 30(4): 384-387

Erythromycin sclerotherapy in the management of seroma. Journal of Plastic, Reconstructive & Aesthetic Surgery 62(3): E55-E58

Erythromycin sensitivity of Micrococcus pyogenes var. aureus in a hospital population (development of resistance). Antibiotics & ChemoTherapy 5(6): 350-352

Erythromycin serum concentrations following administration in acid-resistant tablets. Antibiotics & ChemoTherapy 3(5): 473-477

Erythromycin therapy of respiratory infections. II. Effects of varying durations of therapy of streptococcal infections on eradication of streptococci and on formation of antistreptolysin O. Antibiotics & ChemoTherapy 4(4): 439-450

Erythromycin to promote bedside placement of a self-propelled nasojejunal feeding tube in non-critically ill patients having pancreatitis: a randomized, double-blind, placebo-controlled study. Nutrition in Clinical Practice 26(2): 181-185

Erythromycin treatment hinders the induction of oral tolerance to fed ovalbumin. Frontiers in Immunology 3: 203-203

Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production. International Journal of Cardiology 167(5): 2228-2233

Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity. Therapeutic Advances in Infectious Disease 2(2): 47-59

Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition. Antimicrobial Agents and ChemoTherapy 53(2): 563-571

Erythromycin- and copper-resistant Enterococcus hirae from marine sediment and co-transfer of erm(B) and tcrB to human Enterococcus faecalis. Diagnostic Microbiology and Infectious Disease 80(1): 26-28

Erythromycin- and tetracycline-resistant lactobacilli in Italian fermented dry sausages. Journal of Applied Microbiology 107(5): 1559-1568

Erythromycin-heteroresistant methicillin-resistant Staphylococcus aureus isolates from Turkey. Clinical Microbiology and Infection 14(6): 626-627

Erythromycin-induced CXCR4 expression on microvascular endothelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 297(3): L420-L431

Erythromycin-induced genotoxicity and hepatotoxicity in mice pups treated during prenatal and postnatal period. Fundamental & Clinical Pharmacology 28(5): 519-529

Erythromycin-induced postprandial biliary colic. New Zealand Medical Journal 122(1301): 57-60

Erythromycin-induced ribosome stalling and RNase J1-mediated mRNA processing in Bacillus subtilis. Molecular Microbiology 69(6): 1439-1449

Erythromycin-resistant genes in group A β-haemolytic Streptococci in Chengdu, Southwestern China. Indian Journal of Medical Microbiology 32(3): 290-293

Erythromycin-resistant group G streptococci in an isolated northern Canadian community. Canadian Journal of Infectious Diseases 1(1): 3-6

Erythrone system in aged patients with chronic cardiac insufficiency. Klinicheskaia Meditsina 87(8): 21-25

Erythronium dens-canis L. (Liliaceae): an unusual case of change of leaf mottling. Plant Physiology and Biochemistry 74: 108-117

Erythronolides H and I, new erythromycin congeners from a new halophilic actinomycete Actinopolyspora sp. YIM90600. Organic Letters 11(6): 1353-1356

Erythrophagocytic megakaryoblasts in acute megakaryoblastic leukaemia. British Journal of Haematology 148(5): 672-672

Erythrophagocytosis by angiogenic endothelial cells is enhanced by loss of erythrocyte deformability. Experimental Hematology 38(4): 282-291

Erythrophagocytosis by blasts in acute myeloid leukaemia harbouring the BCR-ABL1 fusion gene. British Journal of Haematology 167(5): 586-586

Erythrophagocytosis by neutrophils. Blood 117(3): 753-753

Erythrophagocytosis by neutrophils associated with Clostridium perfringens-induced hemolytic anemia. Annals of Hematology 94(3): 521-522

Erythrophagocytosis by neutrophils--a rare morphological phenomenon resulting in acquired haemolytic anaemia?. International Journal of Laboratory Hematology 33(4): 447-450

Erythrophagocytosis enhances heme-dependent cytotoxicity of antimalarial drugs in canine histiocytic sarcoma cell line DH82. Journal of Veterinary Medical Science 76(2): 249-253

Erythrophagocytosis in Entamoeba histolytica and Entamoeba dispar: a comparative study. Biomed Research International 2014: 626259-626259

Erythrophagocytosis in acute hemolytic anemia of the newborn; a report of three cases. American Journal of Diseases of Children 71: 269-276

Erythrophagocytosis in circulating blood of loggerhead turtles Caretta caretta: the pitting of Heinz bodies. Journal of Experimental Zoology. Part A, Ecological Genetics and Physiology 321(3): 144-150

Erythrophagocytosis in cold agglutinin disease. Journal of Pediatric Hematology/Oncology 33(5): 398-398

Erythrophagocytosis in hemolytic disease of the newborn. American Journal of Hematology 83(8): 679-679

Erythrophagocytosis of desialylated red blood cells is responsible for anaemia during Trypanosoma vivax infection. Cellular Microbiology 15(8): 1285-1303

Erythrophagocytosis of lead-exposed erythrocytes by renal tubular cells: possible role in lead-induced nephrotoxicity. Environmental Health Perspectives 123(2): 120-127

Erythrophagocytosis: a new diagnostic marker of immunologic myocardial damage in ischemic heart disease. Kardiologiia 53(9): 12-14

Erythrophobia--problems of diagnostics and treatment. Polski Przeglad Chirurgiczny 84(6): 322-327

Erythrophore cell response to food-associated pathogenic bacteria: implications for detection. Microbial Biotechnology 1(5): 425-431

Erythroplasia. Proceedings of the Royal Society of Medicine 35(5): 385-385

Erythroplasia of Queyrat of the glans penis on a background of Zoon's plasma cell balanitis. Australasian Journal of Dermatology 49(2): 103-105

Erythroplasia of Queyrat refractory to photodynamic therapy. Clinical and Experimental Dermatology 37(7): 795-797

Erythroplasia of Queyrat with Zoon's balanitis: a diagnostic dilemma. International Journal of Std & Aids 19(12): 861-863

Erythroplasia of Queyrat; report of a case. Journal of Urology 60(5): 776-779

Erythroplasia of Queyrat; report of ten cases. Archives of Dermatology and Syphilology 58(2): 184-190

Erythroplasia of queyrat. Clinics and Practice 2(3): E63-E63

Erythropoeisis-stimulating agents (ESAs) in cervix cancer: The "black box" paradox. Cancer Biology & Therapy 8(1): 18-20

Erythropoesis-stimulating agents: 21 years of clinical experience. Acta Medica Croatica 63 Suppl 1: 1-2

Erythropoesis-stimulating agents: past, present and future. Acta Medica Croatica 63 Suppl 1: 3-6

Erythropoetic-stimulating agents: where do we stand?. Annals of Oncology 19 Suppl 7: Vii137-40

Erythropoetin as a novel agent with pleiotropic effects against acute lung injury. European Journal of Clinical Pharmacology 67(1): 1-9

Erythropoetin beta twice weekly versus standard therapy in patients with gynaecological malignancies--a randomised Austrian AGO trial. Anticancer Research 28(6b): 3977-3984

Erythropoetin receptor expression in the human diabetic retina. Bmc Research Notes 2(): 234-234

Erythropoetin treatment significantly alters measured glycated haemoglobin (HbA1c). Diabetic Medicine 25(2): 239-240

Erythropoiesis and enucleation. Japanese Journal of Clinical Hematology 54(7): 617-627

Erythropoiesis and iron metabolism biorhythms in children with chronic pyelonephritis. Bulletin of Experimental Biology and Medicine 146(3): 297-300

Erythropoiesis and iron sulfur cluster biogenesis. Advances in Hematology 2010: -

Erythropoiesis and the approach to anemia in premature infants. Journal of Maternal-Fetal & Neonatal Medicine 25(Suppl 5): 97-99

Erythropoiesis and the mystery of an unexplained survival benefit. Annals of Surgery 251(1): 5-5

Erythropoiesis equivalence, pharmacokinetics and immune response following repeat hematide administration in cynomolgus monkeys. International Journal of Immunopathology and Pharmacology 23(1): 121-129

Erythropoiesis failure due to RPS19 deficiency is independent of an activated Tp53 response in a zebrafish model of Diamond-Blackfan anaemia. British Journal of Haematology 152(5): 648-654

Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signaling. Stem Cells 32(6): 1503-1514

Erythropoiesis in HIV-infected and uninfected Malawian children with severe anemia. Aids 24(18): 2883-2887

Erythropoiesis is regulated by the transcription elongation factor Foggy/Spt5 through gata1 gene regulation. Genes to Cells 16(2): 231-242

Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study. Annals of Surgery 251(1): 1-4

Erythropoiesis stimulating agents. Therapeutische Umschau. Revue Therapeutique 68(11): 650-654

Erythropoiesis stimulating agents (ESAs) for congestive heart failure: the red and the black. European Journal of Internal Medicine 25(2): 193-196

Erythropoiesis stimulating agents and anaemia of end-stage renal disease. Cardiovascular & Hematological Agents in Medicinal Chemistry 8(3): 164-172

Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy. Breast Cancer Research and Treatment 148(1): 175-185

Erythropoiesis stimulating agents and other growth factors in low-risk MDS. Best Practice & Research. Clinical Haematology 26(4): 401-410

Erythropoiesis stimulating agents and techniques: a challenge for doping analysts. Current Medicinal Chemistry 16(10): 1236-1247

Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level. European Journal of Haematology 83(2): 154-155

Erythropoiesis stimulating agents in heart failure patients with anemia: a meta-analysis. Cardiovascular Drugs and Therapy 23(6): 511-518

Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine. American Journal of Hematology 85(11): 835-837

Erythropoiesis stimulating agents, thrombosis and cancer. RadioTherapy and Oncology 95(3): 269-276

Erythropoiesis stimulating agents: a personal journey. Journal of the National Cancer Institute 105(14): 999-1001

Erythropoiesis stimulating agents: approaches to modulate activity. Biologics 7: 161-174

Erythropoiesis stimulating proteins for the treatment of anemia in cancer patients. Therapeutische Umschau. Revue Therapeutique 67(5): 271-276

Erythropoiesis stimulation in acute ischemic syndromes. Heart Failure Clinics 6(3): 313-321

Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management. Blood Purification 29(1): 1-12

Erythropoiesis suppression is associated with anthrax lethal toxin-mediated pathogenic progression. Plos One 8(8): E71718-E71718

Erythropoiesis, anemia and the bone marrow microenvironment. International Journal of Hematology 93(1): 10-13

Erythropoiesis, erythropoietin and blood lead levels. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 33(1): 37-40

Erythropoiesis- and thrombopoiesis-characterizing parameters in adenosine A3 receptor knock-out mice. Physiological Research 62(3): 305-311

Erythropoiesis- stimulating agents: continued challenges. Journal of Oncology Practice 3(5): 248-253

Erythropoiesis--once more HIF!. Blood 112(4): 931-932

Erythropoiesis-Stimulating Agent (ESA) Practice Patterns in Patients With Chemotherapy-Induced Anemia (CIA) Treated at Hospital Oncology Clinics. Hospital Pharmacy 48(2): 120-126

Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15. American Journal of Hematology 89(4): 385-390

Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease. Journal of Clinical & Cellular Immunology 4(6): 179-179

Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology 12(4): 321-330

Erythropoiesis-stimulating agent hyporesponsiveness in dialysis patients: be aware of subclinical hypothyroidism. Nephrology 18(6): 478-478

Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients. Bmc Nephrology 14(): 200-200

Erythropoiesis-stimulating agent use after changes in medicare reimbursement policies. Journal of Oncology Practice 10(4): 264-269

Erythropoiesis-stimulating agent use among non-dialysis-dependent CKD patients before and after the trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) using a large US health plan database. American Journal of Kidney Diseases 64(5): 706-713

Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives. Clinical Cancer Research 14(15): 4685-4690

Erythropoiesis-stimulating agent withdrawal and oxidative stress in hemodialysis. Clinical Nephrology 71(5): 521-526

Erythropoiesis-stimulating agents. Cancer Treatment and Research 157: 55-74

Erythropoiesis-stimulating agents (ESA) for preventing the progression of chronic kidney disease: a meta-analysis of 19 studies. American Journal of Nephrology 40(3): 263-279

Erythropoiesis-stimulating agents (ESAs), from chemotherapy-induced anemia to any cancer-related anemia?. Annals of Oncology 21(4): 905-906

Erythropoiesis-stimulating agents and heart failure. Cardiovascular Therapeutics 29(4): E52-E59

Erythropoiesis-stimulating agents and thrombotic events in dialysis patients. Thrombosis Research 134(5): 1081-1086

Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma. American Journal of Hematology 83(9): 697-701

Erythropoiesis-stimulating agents are effective in myelodysplastic syndromes, but are they safe?. American Journal of Hematology 84(1): 3-5

Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database of Systematic Reviews (): Cd007613-Cd007613

Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis. Cochrane Database of Systematic Reviews (): Cd000332-Cd000332

Erythropoiesis-stimulating agents for anemic patients with cancer. Expert Review of Hematology 3(6): 697-704

Erythropoiesis-stimulating agents for the management of anemia of chronic kidney disease: past advancements and current innovations. Nephrology Nursing Journal 39(6): 447-457

Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience. Journal of Blood Medicine 5(): 43-48

Erythropoiesis-stimulating agents in a meta-stable state: guidelines, economics, and policy in flux. American Health & Drug Benefits 1(9): 14-18

Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation. Expert Opinion on Biological Therapy 15(2): 195-211

Erythropoiesis-stimulating agents in anemia: use and misuse. Journal of the American Medical Directors Association 10(9): 607-616

Erythropoiesis-stimulating agents in cancer. Journal of Clinical Oncology 26(18): 3097-8; Author Reply 3098-100

Erythropoiesis-stimulating agents in cancer patients: ESMO recommendations for use. Annals of Oncology 20 Suppl 4: 159-161

Erythropoiesis-stimulating agents in cancer patients: reflections on safety. Expert Review of Clinical Pharmacology 4(4): 467-476

Erythropoiesis-stimulating agents in chronic kidney disease: what have we learned in 25 years?. Journal of the Formosan Medical Association 113(1): 3-10

Erythropoiesis-stimulating agents in chronic kidney disease: which route of administration?. Giornale Italiano di Nefrologia 26(1): 31-37

Erythropoiesis-stimulating agents in congestive heart failure patients. Medicina Clinica 142(5): 215-218

Erythropoiesis-stimulating agents in heart failure: no proof of effectiveness or proof of no effectiveness?. European Journal of Heart Failure 15(8): 944-945

Erythropoiesis-stimulating agents in myelodysplastic syndromes. Leukemia & Lymphoma 51(7): 1155-1156

Erythropoiesis-stimulating agents in ovarian cancer patients receiving chemotherapy: to treat or not to treat?. International Journal of Gynecological Cancer 23(5): 783-784

Erythropoiesis-stimulating agents in patients with cancer: update on safety issues. Expert Opinion on Drug Safety 8(5): 515-522

Erythropoiesis-stimulating agents in renal medicine. Oncologist 16 Suppl 3: 19-24

Erythropoiesis-stimulating agents in the management of cancer patients with anemia: a meta-analysis. Chinese Journal of Cancer Research 26(3): 268-276

Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use. Annals of Oncology 21 Suppl 5: V244-V247

Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia. JAMA 300(24): 2855; Author Reply 2855-7

Erythropoiesis-stimulating agents on trial: are higher dosages causing harm?. American Journal of Kidney Diseases 61(1): 6-8

Erythropoiesis-stimulating agents versus RBC transfusion in MDS: comparison of long-term outcomes. Future Oncology 3(4): 397-403

Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient. Current Opinion in Nephrology and Hypertension 20(5): 465-470

Erythropoiesis-stimulating agents--time for a reevaluation. New England Journal of Medicine 362(3): 189-192

Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer. Current Oncology 15(Suppl 1): S10-S15

Erythropoiesis-stimulating agents: creation and validation of a computerized prescriber order entry alert. Annals of PharmacoTherapy 43(6): 1143-1144

Erythropoiesis-stimulating agents: development, detection and dangers. Drug Testing and Analysis 1(6): 245-249

Erythropoiesis-stimulating agents: favorable safety profile when used as indicated. Strahlentherapie und Onkologie 184(9): 490-490

Erythropoiesis-stimulating agents: friends or foes?. Transfusion 53(9): 1867-1872

Erythropoiesis-stimulating agents: from the origins to new challenges. Giornale Italiano di Nefrologia 27 Suppl 52: S38-S46

Erythropoiesis-stimulating agents: switch from intravenous to subcutaneous administration in hemodialyzed patients. International Journal of Clinical Pharmacology and Therapeutics 49(12): 744-749

Erythropoiesis-stimulating agents: the present situation. Clinical & Translational Oncology 13(5): 287-288

Erythropoiesis-stimulating properties of an antiserotonin drug under cytostatic treatment conditions. Eksperimental'naia i Klinicheskaia Farmakologiia 73(3): 21-24

Erythropoiesis-stimulating protein delivery in providing erythropoiesis and neuroprotection. Expert Opinion on Drug Delivery 5(12): 1313-1321

Erythropoiesis: early, not primitive. Blood 117(18): 4685-4686

Erythropoiesis: model systems, molecular regulators, and developmental programs. Iubmb Life 61(8): 800-830

Erythropoietic activity of Asteracantha longifolia (Nees.) in rats. Journal of Ethnopharmacology 129(2): 280-282

Erythropoietic agents and the elderly. Seminars in Hematology 45(4): 267-275

Erythropoietic agents for anemia of critical illness. American Journal of Health-System Pharmacy 65(6): 540-546

Erythropoietic agents from natural sources. Alternative Therapies in Health and Medicine 19(6): 54-60

Erythropoietic agents, iron and hemoglobin--What happens beyond the trial setting: observational data from the ANZDATA registry. Hemodialysis International. International Symposium on Home Hemodialysis 8(3): 257-264

Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models. Journal of Physiology 589(Pt 6): 1259-1264

Erythropoietic defect associated with reduced cell proliferation in mice lacking the 26S proteasome shuttling factor Rad23b. Molecular and Cellular Biology 33(19): 3879-3892

Erythropoietic differentiation of a human embryonic stem cell line harbouring the sickle cell anaemia mutation. Reproductive Biomedicine Online 21(2): 196-205

Erythropoietic growth factors for children with cancer: a systematic review of the literature. Current Medical Research and Opinion 23(11): 2841-2847

Erythropoietic neuroprotection: Holy Grail or potential to fail?. Intensive Care Medicine 37(9): 1403-1405

Erythropoietic porphyrias. Duodecim; Laaketieteellinen Aikakauskirja 128(12): 1257-1263

Erythropoietic porphyrias: animal models and update in gene-based therapies. Current Gene Therapy 8(3): 176-186

Erythropoietic potential of CD34+ hematopoietic stem cells from human cord blood and G-CSF-mobilized peripheral blood. Biomed Research International 2014: 435215-435215

Erythropoietic protein supportive treatment in small cell lung cancer. Magyar Onkologia 52(1): 43-46

Erythropoietic protoporphyria. Clinical Gastroenterology and Hepatology 8(8): E82-E82

Erythropoietic protoporphyria. Annales de Dermatologie et de Venereologie 138(1): 62-4; Quiz 61, 65

Erythropoietic protoporphyria (Report of three cases). Indian Journal of Dermatology, Venereology and Leprology 61(5): 320-322

Erythropoietic protoporphyria and early onset of cholestasis. Turkish Journal of Pediatrics 54(6): 645-650

Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices. Liver Transplantation 13(5): 655-657

Erythropoietic protoporphyria in Sweden: demographic, clinical, biochemical and genetic characteristics. Journal of Internal Medicine 269(3): 278-288

Erythropoietic protoporphyria in a boy. Archives of Disease in Childhood 100(1): 7-7

Erythropoietic protoporphyria masquerading as angioedema in a 4-year-old female. Allergy, Asthma, and Clinical Immunology 2(1): 20-23

Erythropoietic protoporphyria patients in Slovenia. Acta Dermatovenerologica Alpina, Pannonica, et Adriatica 16(3): 99-102, 104

Erythropoietic protoporphyria with eye complications. Journal of Dermatology 34(11): 790-794

Erythropoietic protoporphyria-like scars and xanthomas in a child with Alagille syndrome. International Journal of Dermatology 53(2): E112-E114

Erythropoietic protoporphyria. A rare differential diagnosis among photosensitive diseases. Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und Verwandte Gebiete 63(12): 961-964

Erythropoietic protoporphyria. A rare inherited metabolic disorder with skin symptoms. Ugeskrift for Laeger 170(5): 352-352

Erythropoietic protoporphyria: a case report and literature review. Journal of Clinical and Aesthetic Dermatology 3(7): 44-48

Erythropoietic protoporphyria: a family study and report of a novel mutation in the FECH gene. European Journal of Dermatology 21(4): 479-483

Erythropoietic protoporphyria: spectrum of three cases. Journal of Cutaneous Medicine and Surgery 16(5): 311-316

Erythropoietic response and outcomes in kidney disease and type 2 diabetes. New England Journal of Medicine 363(12): 1146-1155

Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants. Journal of Pharmacology and Experimental Therapeutics 332(1): 229-237

Erythropoietic response to erythropoiesis-stimulating agents and outcome: should we give up the haemoglobin target approach?. Nephrology, Dialysis, Transplantation 26(7): 2069-2071

Erythropoietic stimulating agents. Expert Opinion on Emerging Drugs 15(1): 119-138

Erythropoietic substances, the folic acid and vitamin B12 group. Medicina, Cirurgia, Farmacia 29(158): 337-359

Erythropoietic therapy: cost efficiency and reimbursement. American Journal of Health-System Pharmacy 64(16 Suppl 11): S19-S29

Erythropoietic therapy: who, how, and when?. Supportive Cancer Therapy 3(2): 125-126

Erythropoietic-stimulating agents (ESAs): new safety warning. Geriatric Nursing 28(3): 148-150

Erythropoietic-stimulating agents: the cancer progression controversy and collateral damage to the blood supply. Transfusion 49(5): 824-826

Erythropoietin. Comprehensive Physiology 1(4): 1759-1794

Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO. Cardiovascular Drugs and Therapy 24(5-6): 401-408

Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues. Journal of Pharmaceutical and Biomedical Analysis 53(4): 1028-1032

Erythropoietin (EPO) in acute kidney injury. Annals of Intensive Care 1(1): 3-3

Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor. Molecular Medicine 19: 223-229

Erythropoietin (EPO) influences colonic anastomotic healing in a rat model by modulating collagen metabolism. Journal of Surgical Research 163(2): E67-E72

Erythropoietin (EPO) protects against high glucose-induced apoptosis in retinal ganglional cells. Cell Biochemistry and Biophysics 71(2): 749-755

Erythropoietin - state of science. Sportverletzung Sportschaden 22(4): 201-206

Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?. Pharmacology & Therapeutics 128(3): 445-459

Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice. Frontiers in Immunology 5: 502-502

Erythropoietin In Miniature Swine Ingesting Sr-90. Hw-76000. Hw-Sa Reports . U.S. Atomic Energy Commission 86: 93-94

Erythropoietin May Improve Anemia in Patients with Autoimmune Hemolytic Anemia Associated with Reticulocytopenia. Transfusion Medicine and HemoTherapy 39(3): 221-223

Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance. Genes & Cancer 1(1): 50-61

Erythropoietin a safe bet in haemorrhagic shock?. Acta Anaesthesiologica Scandinavica 52(5): 585-586

Erythropoietin accelerates functional recovery after peripheral nerve injury. Journal of Bone and Joint Surgery. American Volume 90(8): 1644-1653

Erythropoietin accelerates smooth muscle cell-rich vascular lesion formation in mice through endothelial cell activation involving enhanced PDGF-BB release. Blood 115(7): 1453-1460

Erythropoietin accelerates the regeneration of ureteral function in a murine model of obstructive uropathy. Journal of Urology 193(2): 714-721

Erythropoietin action in stress response, tissue maintenance and metabolism. International Journal of Molecular Sciences 15(6): 10296-10333

Erythropoietin activates Keap1-Nrf2/ARE pathway in rat brain after ischemia. International Journal of Neuroscience 124(5): 362-368

Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy. Cancer Research 73(21): 6393-6400

Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the heart. Circulation Research 106(11): 1722-1730

Erythropoietin activates nitric oxide synthase in murine erythrocytes. American Journal of Physiology. Cell Physiology 297(2): C378-C388

Erythropoietin activates telomerase through transcriptional and posttranscriptional regulation in human erythroleukemic JAS-REN-A cells. Leukemia Research 35(3): 416-418

Erythropoietin adjuvant therapy and sustained virological response in HCV-infected patients. Alimentary Pharmacology & Therapeutics 32(3): 509-510

Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. Faseb Journal 23(2): 351-361

Erythropoietin administration alone or in combination with endurance training affects neither skeletal muscle morphology nor angiogenesis in healthy young men. Experimental Physiology 99(10): 1409-1420

Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: is it still a reasonable option or too dangerous?. Oral Oncology 45(2): 91-93

Erythropoietin administration facilitates return of spontaneous circulation and improves survival in a pig model of cardiac arrest. American Journal of Emergency Medicine 32(8): 871-877

Erythropoietin administration for prevention of cardiac surgery-associated acute kidney injury: a meta-analysis of randomized controlled trials. European Journal of Cardio-Thoracic Surgery 48(1): 32-39

Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica 95(3): 505-508

Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury. Acta Anaesthesiologica Scandinavica 55(2): 185-195

Erythropoietin administration modulates pulmonary Nrf2 signaling pathway after traumatic brain injury in mice. Journal of Trauma 71(3): 680-686

Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models. Journal of Lipid Research 54(11): 3045-3051

Erythropoietin ameliorates damage to the placenta and fetal liver induced by exposure to lipopolysaccharide. Placenta 31(4): 282-288

Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver. World Journal of Gastroenterology 16(38): 4838-4845

Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study. Journal of Nephropathology 1(2): 109-116

Erythropoietin ameliorates oxidative stress and tissue injury following renal ischemia/reperfusion in rat kidney and lung. Medical Principles and Practice 22(1): 70-74

Erythropoietin ameliorates rat experimental autoimmune neuritis by inducing transforming growth factor-β in macrophages. Plos One 6(10): E26280-E26280

Erythropoietin ameliorates the motor and cognitive function impairments in a rat model of hepatic cirrhosis. Metabolic Brain Disease 30(1): 197-204

Erythropoietin ameliorates the reduced migration of human fibroblasts during in vitro hypoxia. Journal of Physiology and Biochemistry 67(1): 1-13

Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat. Plos One 5(6): E11016-E11016

Erythropoietin analogues: an unnecessary class of drugs. Lancet. Oncology 9(2): 81-81

Erythropoietin and HAPE. Aviation, Space, and Environmental Medicine 79(8): 807-807

Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia. Current Neurovascular Research 8(4): 270-285

Erythropoietin and amyotrophic lateral sclerosis: Plasma level determination. Amyotrophic Lateral Sclerosis 12(6): 439-443

Erythropoietin and analogs. Handbook of Experimental Pharmacology: 251-294

Erythropoietin and anemia in aging and frailty. Journal of the American Geriatrics Society 56(11): 2164-2165

Erythropoietin and anemia: biological markers that cannot be ignored in diabetic retinopathy. Medical Hypotheses 78(4): 555-556

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis. Anatomy & Cell Biology 45(4): 215-220

Erythropoietin and blood oxygen transport: new sides of well-known problem. Eksperimental'naia i Klinicheskaia Farmakologiia 75(1): 39-42

Erythropoietin and cancer, a double-edged sword. Leukemia Research 33(1): 1-4

Erythropoietin and cancer: an old risk. American Journal of Kidney Diseases 53(6): 1102; Author Reply 1102-3

Erythropoietin and cyclophosphamide combination treatment additively enhances antibody production in mice. Acta Haematologica 123(2): 81-83

Erythropoietin and cytoprotective cytokines in experimental traumatic brain injury. Methods in Molecular Biology 982: 141-162

Erythropoietin and engineered innate repair activators. Methods in Molecular Biology 982: 1-11

Erythropoietin and epidemiology of Alzheimer disease. Alzheimer Disease and Associated Disorders 27(3): 204-206

Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer. Clinical Cancer Research 13(16): 4825-4831

Erythropoietin and erythropoietin receptor expression in normal and disturbed pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 140(2): 192-200

Erythropoietin and erythropoietin receptor in colorectal cancer. International Journal of Surgical Pathology 16(3): 269-276

Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. Journal of Clinical Oncology 26(21): 3607-3613

Erythropoietin and growth factors exhibit differential angiogenic potential in mouse heart. In Vivo 22(5): 587-591

Erythropoietin and heart failure: the end of a promise?. European Journal of Heart Failure 15(5): 479-481

Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cells. Cytokine 54(2): 129-135

Erythropoietin and intravenous iron in PBM. Transfusion and Apheresis Science 50(1): 16-19

Erythropoietin and intravenous iron therapy in postpartum anaemia. Acta Obstetricia et Gynecologica Scandinavica 86(8): 957-962

Erythropoietin and ischemic conditioning--why two good things may be bad. Acta Paediatrica 96(6): 787-789

Erythropoietin and its emerging neuroprotective effects. International Journal of Neuroscience 123(8): 591-592

Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?. International Journal of Urology 15(11): 1011-1017

Erythropoietin and its receptor in breast cancer: putting together the pieces of the puzzle. Oncologist 13(7): 761-768

Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria. Malaria Journal 8(): 261-261

Erythropoietin and mesenchymal stromal cells in angiogenesis and myocardial regeneration: one plus one equals three?. Cardiovascular Research 79(3): 357-359

Erythropoietin and microvascular diabetic complications. Nephrology, Dialysis, Transplantation 24(2): 388-390

Erythropoietin and myocardial infarction. Clinical and Translational Science 4(6): 478-478

Erythropoietin and neonatal brain injury. Zhonghua Er Ke Za Zhi 49(10): 756-760

Erythropoietin and neuroprotection. Archives de Pediatrie 17 Suppl 3: S78-S84

Erythropoietin and outcome prediction in patients with heart failure: the plot thickens... European Heart Journal 29(12): 1481-1482

Erythropoietin and prenatal hypoxia-ischemia. Journal of Neurosurgery. Pediatrics 6(3): 203-5; Discussion 205

Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial). Anesthesiology 121(3): 582-590

Erythropoietin and radiotherapy. Cancer Radiotherapie 14(1): 81-86

Erythropoietin and renal protection. Daru 21(1): 78-78

Erythropoietin and renoprotection. Current Opinion in Nephrology and Hypertension 18(1): 15-20

Erythropoietin and resistant hypertension in CKD. Seminars in Nephrology 34(5): 540-549

Erythropoietin and retinopathy of prematurity. Early Human Development 87 Suppl 1: S39-S42

Erythropoietin and retinopathy of prematurity: a meta-analysis. European Journal of Pediatrics 173(10): 1355-1364

Erythropoietin and retinopathy: the beginning of an understanding. British Journal of Ophthalmology 92(4): 574-574

Erythropoietin and soluble CD44 levels in patients with primary open-angle glaucoma. Clinical & Experimental Ophthalmology 38(6): 560-565

Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition. Neurobiology of Disease 40(1): 146-154

Erythropoietin and subarachnoid hemorrhage. World Neurosurgery 73(5): 461-462

Erythropoietin and the 15 cities young stroke study. International Journal of Stroke 8(6): E34-E34

Erythropoietin and the effect of oxygen during proliferation and differentiation of human neural progenitor cells. Bmc Cell Biology 11(): 94-94

Erythropoietin and the heart: facts and perspectives. Clinical Science 120(2): 51-63

Erythropoietin and the heart: physiological effects and the therapeutic perspective. International Journal of Cardiology 171(2): 116-125

Erythropoietin and the pro-inflammatory cytokines in chronic C hepatitis. Hepato-Gastroenterology 56(91-92): 751-755

Erythropoietin and the regulation of red blood cell formation. Physiology for Physicians 1: 1-6

Erythropoietin and the sex-dimorphic chemoreflex pathway. Advances in Experimental Medicine and Biology 758: 55-62

Erythropoietin and the truths of science. Journal of Nephrology 24(5): 564-568

Erythropoietin and the vascular wall: the controversy continues. Nutrition, Metabolism, and Cardiovascular Diseases 23 Suppl 1(): S37-S43

Erythropoietin and treatment of non-anemic conditions--cardiovascular protection. Seminars in Hematology 44(3): 212-217

Erythropoietin and tumor angiogenesis. Stem Cells and Development 19(1): 1-4

Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes. European Journal of Endocrinology 163(3): 391-398

Erythropoietin and ventricular remodelling: a VEGF-dependent neovascularity. Cardiovascular Research 87(1): 6-7

Erythropoietin as a cardioprotective agent: down but not out. Heart 97(19): 1537-1539

Erythropoietin as a neuroprotectant for neonatal brain injury: animal models. Methods in Molecular Biology 982: 113-126

Erythropoietin as a neuroprotective agent. Neonatal Network 30(2): 135-139

Erythropoietin as a neuroprotective agent in traumatic brain injury Review. Surgical Neurology 71(5): 527-31; Discussion 531

Erythropoietin as a new player in multiple neurohumoral dysregulations underlying chronic heart failure and therapeutic strategies against them. International Journal of Cardiology 168(3): 2871-2872

Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases. International Journal of Neuroscience 125(11): 793-797

Erythropoietin as a novel brain and kidney protective agent. Anaesthesia and Intensive Care 39(3): 356-372

Erythropoietin as a novel therapeutic agent for atrophic age-related macular degeneration. Medical Hypotheses 72(4): 448-450

Erythropoietin as a possible mechanism for the effects of intermittent hypoxia on bodyweight, serum glucose and leptin in mice. Regulatory Peptides 165(2-3): 168-173

Erythropoietin as a protective factor in radiotherapy on cells in the central nervous system: quercetin and its potential associative effect. Revista de Neurologia 59(2): 96-96

Erythropoietin as a protective factor in rat CNS cells receiving radiotherapy -an in vitro study. Revista de Neurologia 58(5): 199-206

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. Nippon Ganka Gakkai Zasshi 111(11): 892-898

Erythropoietin as additive of HTK preservation solution in cold ischemia/reperfusion injury of steatotic livers. Journal of Surgical Research 173(1): 171-179

Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. Cochrane Database of Systematic Reviews (): Cd006158-Cd006158

Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Practice & Research. Clinical Anaesthesiology 24(4): 573-594

Erythropoietin attenuates brain injury, subventricular zone expansion, and sensorimotor deficits in hypoxic-ischemic neonatal rats. Journal of Korean Medical Science 23(3): 484-491

Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor. Disease Models & Mechanisms 6(4): 1021-1030

Erythropoietin attenuates cardiopulmonary bypass-induced renal inflammatory injury by inhibiting nuclear factor-κB p65 expression. European Journal of Pharmacology 689(1-3): 154-159

Erythropoietin attenuates hydrogen peroxide-induced damage of hepatocytes. Turkish Journal of Gastroenterology 18(4): 239-244

Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases. Developmental Neuroscience 31(5): 394-402

Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain. Brain, Behavior, and Immunity 24(5): 792-799

Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro. Scandinavian Journal of Clinical and Laboratory Investigation 69(4): 518-525

Erythropoietin attenuates inflammatory factors and cell death in neonatal rats with intracerebral hemorrhage. Acta Neurochirurgica. Supplement 111: 299-305

Erythropoietin attenuates intracerebral hemorrhage by diminishing matrix metalloproteinases and maintaining blood-brain barrier integrity in mice. Acta Neurochirurgica. Supplement 105: 105-112

Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression. European Journal of Pharmacology 602(2-3): 406-412

Erythropoietin attenuates loss of potassium chloride co-transporters following prenatal brain injury. Molecular and Cellular Neurosciences 61: 152-162

Erythropoietin attenuates lung injury in lipopolysaccharide treated rats. Journal of Surgical Research 155(1): 104-110

Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Molecular Medicine 18: 628-635

Erythropoietin attenuates oxidative stress and apoptosis in Schwann cells isolated from streptozotocin-induced diabetic rats. Journal of Pharmacy and Pharmacology 66(8): 1150-1160

Erythropoietin attenuates renal injury in an experimental model of rat unilateral ureteral obstruction via anti-inflammatory and anti-apoptotic effects. Journal of Urology 181(3): 1434-1443

Erythropoietin attenuates the sequels of ischaemic spinal cord injury with enhanced recruitment of CD34+ cells in mice. Journal of Cellular and Molecular Medicine 16(8): 1792-1802

Erythropoietin attenuates white matter damage, proinflammatory cytokine and chemokine induction in developing rat brain after intra-uterine infection. Neuropathology 29(5): 528-535

Erythropoietin augments bone formation in a rabbit posterolateral spinal fusion model. Journal of Orthopaedic Research 30(7): 1083-1088

Erythropoietin augments survival of glioma cells after radiation and temozolomide. International Journal of Radiation Oncology, Biology, Physics 72(3): 927-934

Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia. Molecular Biology Reports 37(3): 1467-1475

Erythropoietin available. Science 188(4183): 8-8

Erythropoietin before severe hypospadias repair: fewer complications?. Progres en Urologie 22(3): 178-181

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. Plos One 2(6): E549-E549

Erythropoietin bundling: innovative remuneration or the dawn of EPO-profiling?. Seminars in Dialysis 23(1): 88-90

Erythropoietin but not VEGF has a protective effect on auditory hair cells in the inner ear. Cellular and Molecular Life Sciences 66(22): 3595-3599

Erythropoietin can promote survival of cerebral cells by downregulating Bax gene after traumatic brain injury in rats. Neurology India 57(6): 722-728

Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function. American Journal of Nephrology 38(2): 124-135

Erythropoietin combined with granulocyte colony‑stimulating factor enhances MMP-2 expression in mesenchymal stem cells and promotes cell migration. Molecular Medicine Reports 4(1): 31-36

Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Journal of Neural Transmission 117(3): 343-347

Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy. Archivos de la Sociedad Espanola de Oftalmologia 83(3): 169-172

Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity 34(1): 61-74

Erythropoietin contributes to slow oxidative muscle fiber specification via PGC-1α and AMPK activation. International Journal of Biochemistry & Cell Biology 45(7): 1155-1164

Erythropoietin corrects thrombocytopenia. American Journal of Medicine 126(10): E3-E4

Erythropoietin couples hematopoiesis with bone formation. Plos One 5(5): E10853-E10853

Erythropoietin critically regulates the terminal maturation of murine and human primitive erythroblasts. Haematologica 98(11): 1778-1787

Erythropoietin decreases carbon tetrachloride-induced hepatic fibrosis by inhibiting transforming growth factor-beta. Chinese Medical Journal 125(17): 3098-3103

Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure. Journal of Cardiovascular Pharmacology 56(5): 506-512

Erythropoietin derived by chemical synthesis. Science 342(6164): 1357-1360

Erythropoietin does not affect TNF and IL-6 production directly. Journal of Biological Regulators and Homeostatic Agents 27(1): 189-196

Erythropoietin does not attenuate cytokine production and inflammation in microglia--implications for the neuroprotective effect of erythropoietin in neurological diseases. Journal of Neuroimmunology 212(1-2): 106-111

Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia. Acta Anaesthesiologica Scandinavica 55(4): 411-421

Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy. American Journal of Gastroenterology 103(8): 2161-2162

Erythropoietin does not preserve motor neurons in a mouse model of familial ALS. Amyotrophic Lateral Sclerosis 8(1): 31-35

Erythropoietin dosing in children with chronic kidney disease: based on body size or on hemoglobin deficit?. Pediatric Nephrology 24(3): 435-437

Erythropoietin down-regulates proximal renal tubular reabsorption and causes a fall in glomerular filtration rate in humans. Journal of Physiology 589(Pt 6): 1273-1281

Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: role of Lyn kinase. Plos One 4(5): E5721-E5721

Erythropoietin during hypoglycaemia in type 1 diabetes: relation to basal renin-angiotensin system activity and cognitive function. Diabetes Research and Clinical Practice 85(1): 75-84

Erythropoietin during porcine aortic balloon occlusion-induced ischemia/reperfusion injury. Critical Care Medicine 36(7): 2143-2150

Erythropoietin effectiveness index : a quantitative definition of resistance in haemodialysis patients with adequate iron stores. Clinical Drug Investigation 15(1): 57-60

Erythropoietin elevates VO2,max but not voluntary wheel running in mice. Journal of Experimental Biology 213(3): 510-519

Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress. Current Neurovascular Research 8(3): 220-235

Erythropoietin encapsulation in chitosan nanoparticles and kinetics of drug release. Current Drug Delivery 8(2): 164-171

Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals. American Journal of Physiology. Cell Physiology 295(2): C394-C405

Erythropoietin enhances arterioles more significantly than it does capillaries in an infarcted rat heart model. International Heart Journal 50(6): 801-810

Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis. Clinical and Experimental Immunology 162(2): 210-223

Erythropoietin enhances hippocampal long-term potentiation and memory. Bmc Biology 6(): 37-37

Erythropoietin enhances hydrogen peroxide-mediated dilatation of canine coronary collateral arterioles during myocardial ischemia in dogs in vivo. American Journal of Physiology. Heart and Circulatory Physiology 299(6): H1928-H1935

Erythropoietin enhances mitochondrial biogenesis in cardiomyocytes exposed to chronic hypoxia through Akt/eNOS signalling pathway. Cell Biology International 38(3): 335-342

Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy. Plos One 6(10): E27067-E27067

Erythropoietin enhances oxygenation in critically perfused tissue through modulation of nitric oxide synthase. Shock 31(6): 599-606

Erythropoietin enhances survival of facial motor neurons by inhibiting expression of inducible nitric oxide synthase after axotomy. Journal of Clinical Neuroscience 17(3): 368-371

Erythropoietin enhances the regeneration of traumatized tissue after combined muscle-nerve injury. Journal of Trauma and Acute Care Surgery 72(6): 1567-1575

Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina. Investigative Ophthalmology & Visual Science 55(12): 8208-8222

Erythropoietin exerts anti-epileptic effects with the suppression of aberrant new cell formation in the dentate gyrus and upregulation of neuropeptide Y in seizure model of rats. Brain Research 1296: 127-136

Erythropoietin exerts cell protective effect by activating PI3K/Akt and MAPK pathways in C6 Cells. Neurological Research 36(3): 215-223

Erythropoietin expands a stromal cell population that can mediate renoprotection. American Journal of Physiology. Renal Physiology 295(4): F1017-F1022

Erythropoietin facilitates resuscitation from ventricular fibrillation by signaling protection of mitochondrial bioenergetic function in rats. American Journal of Translational Research 5(3): 316-326

Erythropoietin facilitates the return of spontaneous circulation and survival in victims of out-of-hospital cardiac arrest. Resuscitation 80(6): 631-637

Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event. Neurosciences 17(2): 151-155

Erythropoietin for hemoglobin H disease. Annals of Hematology 88(2): 179-180

Erythropoietin for infants with hypoxic-ischemic encephalopathy. Current Opinion in Pediatrics 22(2): 139-145

Erythropoietin for neonatal brain injury: opportunity and challenge. International Journal of Developmental Neuroscience 29(6): 583-591

Erythropoietin for oncology supportive care. Experimental Cell Research 317(9): 1246-1254

Erythropoietin for stroke treatment: dead or alive?. Critical Care 15(2): 129-129

Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?. World Neurosurgery 77(1): 46-48

Erythropoietin for the treatment of chemotherapy-induced anemia. Japanese Journal of Clinical Hematology 48(10): 1435-1441

Erythropoietin for the treatment of subarachnoid hemorrhage: a review. World Neurosurgery 73(5): 500-507

Erythropoietin for traumatic brain injury. JAMA 312(18): 1928-1929

Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system. Journal of Controlled Release 157(3): 437-444

Erythropoietin gene-modified conditioned medium of human mesenchymal cells promotes hematopoietic development from human embryonic stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(4): 976-980

Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate. Journal of Experimental Medicine 211(2): 181-188

Erythropoietin has a restorative effect on the contractility of arteries following experimental hypoxia. Journal of Cardiovascular Disease Research 4(3): 164-169

Erythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury. Journal of Neurotrauma 31(4): 358-369

Erythropoietin improved initial resuscitation and increased survival after cardiac arrest in rats. Resuscitation 80(6): 696-700

Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 124(2): E218-E226

Erythropoietin improves brain development in short-term hypoxia in rat embryo cultures. Brain & Development 36(10): 864-869

Erythropoietin improves brain mitochondrial function in rats after traumatic brain injury. Neurological Research 31(5): 496-502

Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. Journal of Neurotrauma 27(1): 205-215

Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting. Journal of Korean Medical Science 27(5): 506-511

Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. Journal of Neuroinflammation 10(): 156-156

Erythropoietin improves neurobehavior by reducing dopaminergic neuron loss in a 6‑hydroxydopamine‑induced rat model. International Journal of Molecular Medicine 34(2): 440-450

Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Annals of Neurology 67(5): 657-666

Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease. Advanced Biomedical Research 1(): 50-50

Erythropoietin improves operant conditioning and stability of cognitive performance in mice. Bmc Biology 7(): 37-37

Erythropoietin improves oxidative stress following spinal cord trauma in rats. Injury 39(12): 1408-1413

Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model. Critical Care 11(3): R58-R58

Erythropoietin improves skeletal muscle microcirculation through the activation of eNOS in a mouse sepsis model. Journal of Trauma 71(5 Suppl 1): S462-S467

Erythropoietin improves spatial delayed alternation in a T-maze in rats subjected to ablation of the prefrontal cortex. Brain Research Bulletin 77(1): 1-7

Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization. Journal of Surgical Research 176(1): E47-E55

Erythropoietin improves the postresuscitation myocardial dysfunction and survival in the asphyxia-induced cardiac arrest model. Shock 28(1): 53-58

Erythropoietin improves the survival of fat tissue after its transplantation in nude mice. Plos One 5(11): E13986-E13986

Erythropoietin in Friedreich ataxia. Journal of Neurochemistry 126 Suppl 1: 80-87

Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial. Movement Disorders 27(3): 446-449

Erythropoietin in amniotic fluid. Journal of Maternal-Fetal & Neonatal Medicine 27(18): 1935-1935

Erythropoietin in amniotic fluid as a potential marker in distinction between growth restricted and constitutionally small fetuses. Journal of Maternal-Fetal & Neonatal Medicine 27(11): 1134-1137

Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability. Amyotrophic Lateral Sclerosis 10(5-6): 410-415

Erythropoietin in anemia of prematurity. Journal of Maternal-Fetal & Neonatal Medicine 25(Suppl 5): 80-84

Erythropoietin in cancer patients. Annual Review of Medicine 60: 181-192

Erythropoietin in cancer patients with anemia. La Tunisie Medicale 85(2): 131-133

Erythropoietin in cancer patients: pros and cons. Current Opinion in Oncology 22(4): 307-311

Erythropoietin in cancer-related anemia. Current Opinion in Oncology 20(6): 685-689

Erythropoietin in cancer: an update. Current Molecular Medicine 8(6): 481-491

Erythropoietin in cancer: the new face of an old friend. Journal of B.U.On. 13(1): 7-16

Erythropoietin in cardiac disease: effective or harmful?. Journal of Cardiovascular Medicine 14(12): 870-878

Erythropoietin in cardioprotection: does it have a future or is it all in the past?. Cardiovascular Research 79(4): 549-550

Erythropoietin in cardiovascular diseases: exploring new avenues. Clinical Science 114(4): 289-291

Erythropoietin in chronic heart failure. Congestive Heart Failure 13(5): 289-292

Erythropoietin in clinical practice. Klinicheskaia Meditsina 85(9): 30-37

Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke. Stroke 41(9): 2071-2076

Erythropoietin in heart and vessels: focus on transcription and signalling pathways. Journal of Thrombosis and Thrombolysis 26(3): 183-187

Erythropoietin in neonatal brain protection: the past, the present and the future. Brain & Development 33(8): 632-643

Erythropoietin in neonates. Anales de Pediatria 73(6): 301-304

Erythropoietin in patients with ST-segment elevation myocardial infarction. JAMA 306(7): 705; Author Reply 706-705; Author Reply 706

Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial. Circulation. Cardiovascular Interventions 3(5): 408-413

Erythropoietin in patients with acute coronary syndrome and its cardioprotective action after percutaneous coronary intervention. Circulation Journal 73(10): 1920-1926

Erythropoietin in patients with acute myocardial infarction: no proof of effectiveness or proof of no effectiveness?. Clinical Cardiology 36(10): E39-E40

Erythropoietin in patients with chronic heart failure. Klinicheskaia Meditsina 87(3): 31-34

Erythropoietin in plastic surgery. Handchirurgie, Mikrochirurgie, Plastische Chirurgie 45(2): 108-119

Erythropoietin in sepsis: a new use for a familiar drug?. Critical Care Medicine 37(3): 1138-1139

Erythropoietin in spinal cord injury. European Spine Journal 18(3): 314-323

Erythropoietin in stroke: quo vadis. Expert Opinion on Biological Therapy 10(6): 937-949

Erythropoietin in the treatment of encephalopathy associated with carbon monoxide poisoning. Progress in Neuro-Psychopharmacology & Biological Psychiatry 33(4): 735-738

Erythropoietin in the treatment of heart failure and ischemia. Kardiologia Polska 65(2): 192-197

Erythropoietin in the treatment of postural orthostatic tachycardia syndrome. American Journal of Therapeutics 19(2): 92-95

Erythropoietin in traumatic brain injury: the "golden bullet" on the horizon?. Neurology India 57(6): 693-694

Erythropoietin increases bioavailability of tetrahydrobiopterin and protects cerebral microvasculature against oxidative stress induced by eNOS uncoupling. Journal of Neurochemistry 131(4): 521-529

Erythropoietin increases circulating endothelial progenitor cells and reduces the formation and progression of cerebral aneurysm in rats. Neuroscience 181: 292-299

Erythropoietin increases endothelial biosynthesis of tetrahydrobiopterin by activation of protein kinase B alpha/Akt1. Hypertension 52(1): 93-99

Erythropoietin increases expression and function of vascular copper- and zinc-containing superoxide dismutase. Hypertension 55(4): 998-1004

Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke. Stroke 44(3): 753-758

Erythropoietin increases neuronal NDPKA expression, and NDPKA up-regulation as well as exogenous application protects cortical neurons from in vitro ischemia-related insults. Cellular and Molecular Neurobiology 34(3): 379-392

Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery. Journal of Pediatric Surgery 44(8): 1540-1545

Erythropoietin increases survival and attenuates fulminant hepatic failure injury induced by D-galactosamine/lipopolysaccharide in mice. Transplantation 92(1): 18-24

Erythropoietin increases the motility of human bone marrow-multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBM-MSCs. Stem Cells and Development 18(3): 411-421

Erythropoietin induces angiogenesis in a manner dependent on the intrinsic auto/paracrine production of interleukin-6 in vitro. International Journal of Cardiology 168(3): 2941-2943

Erythropoietin induces excessive neointima formation: a study in a rat carotid artery model of vascular injury. Journal of Cardiovascular Pharmacology and Therapeutics 12(3): 237-247

Erythropoietin induces insulin-like growth factor-1 from three-dimensional culture of human dermal papilla cells. Journal of Dermatological Science 69(1): 82-84

Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SH-SY5Y cells. Cell Biochemistry and Function 28(3): 197-201

Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects. Biological Psychiatry 66(3): 267-274

Erythropoietin influence on oxygen transport function of blood and prooxidant/antioxidant balance in rabbits under lipopolysaccharide injection. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 96(1): 43-49

Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia. Translational Stroke Research 5(1): 118-127

Erythropoietin inhibits angiotensin II induced cardiomyocyte hypertrophy in vitro via activating PI3K/Akt-eNOS pathway. Zhonghua Xin Xue Guan Bing Za Zhi 37(5): 436-440

Erythropoietin inhibits gamma-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line. Clinical and Experimental Pharmacology & Physiology 37(5-6): 624-629

Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice. Plos One 8(1): E53557-E53557

Erythropoietin inhibits liver gelatinases during galactosamine-induced hepatic damage in rats. Pharmacological Reports 61(5): 917-923

Erythropoietin inhibits osmotic swelling of retinal glial cells by Janus kinase- and extracellular signal-regulated kinases1/2-mediated release of vascular endothelial growth factor. Neuroscience 165(4): 1147-1158

Erythropoietin inhibits post-ischemic leukocyte adhesion but does not affect rejection in murine cardiac allografts. Journal of Heart and Lung Transplantation 29(10): 1185-1192

Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury. European Respiratory Journal 33(6): 1403-1414

Erythropoietin inhibits the increase of intestinal labile zinc and the expression of inflammatory mediators after traumatic brain injury in rats. Journal of Trauma 66(3): 730-736

Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions. Journal of Hematology & Oncology 6(): 65-65

Erythropoietin is detectable in the ascitic fluid in patients with ovarian tumors. International Journal of Gynecological Cancer 22(9): 1470-1473

Erythropoietin is equally effective as fresh-blood transfusion at reducing infarct size in anemic rats. Critical Care Medicine 38(11): 2215-2221

Erythropoietin is increased in aqueous humor of glaucomatous eyes. Current Eye Research 35(8): 680-684

Erythropoietin is involved in angiogenesis in human primary melanoma. International Journal of Experimental Pathology 91(6): 495-499

Erythropoietin is neuroprotective in a preterm ovine model of endotoxin-induced brain injury. Journal of Neuropathology and Experimental Neurology 69(3): 306-319

Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy. Movement Disorders 26(3): 507-515

Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function. Nephrology, Dialysis, Transplantation 25(10): 3256-3260

Erythropoietin level in tear and blood plasma of people with myopia including those who wear soft contact lens. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 98(5): 665-675

Erythropoietin levels are not independently associated with malaria-attributable severe disease in Mozambican children. Plos One 6(8): E24090-E24090

Erythropoietin levels in aqueous humor of patients with glaucoma. Molecular Vision 18(): 1991-1995

Erythropoietin levels in aqueous humour in eyes with exudative age-related macular degeneration and diabetic retinopathy. Clinical & Experimental Ophthalmology 35(2): 186-187

Erythropoietin levels in cardiac resynchronization therapy responders. International Journal of Cardiology 145(3): E109-E110

Erythropoietin levels in endocrinopathies. Journal of Endocrinological Investigation 34(6): 427-430

Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan. American Heart Journal 157(1): 91-96

Erythropoietin levels in human tear fluid. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 96(11): 1103-1106

Erythropoietin levels in patients with multiple sclerosis complicated with anemia. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 35(1): 84-87

Erythropoietin levels in patients with sickle cell disease do not correlate with known inducers of erythropoietin. Hemoglobin 38(6): 385-389

Erythropoietin levels in perioperative period in cancer patients. Bulletin du Cancer 94(4): 411-414

Erythropoietin markedly attenuates brain infarct size and improves neurological function in the rat. Journal of Investigative Medicine 58(7): 893-904

Erythropoietin may improve the Outcome in Infants with Moderate to Severe Hypoxic Ischemic Encephalopathy. Journal of Clinical Neonatology 2(1): 8-9

Erythropoietin mediated bone formation is regulated by mTOR signaling. Journal of Cellular Biochemistry 113(1): 220-228

Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 111(12): 5727-5733

Erythropoietin mimetic compound AGEM400(HES) binds to the same receptor as erythropoietin but displays a different spectrum of activities. Cytokine 57(2): 226-237

Erythropoietin modulates autophagy signaling in the developing rat brain in an in vivo model of oxygen-toxicity. International Journal of Molecular Sciences 13(10): 12939-12951

Erythropoietin modulates imbalance of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in doxorubicin-induced cardiotoxicity. Heart, Lung & Circulation 23(8): 772-777

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients. Psychopharmacology 210(3): 419-428

Erythropoietin modulates the immune-inflammatory response of a SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS). Neuroscience Letters 574: 53-58

Erythropoietin modulates the neural control of hypoxic ventilation. Cellular and Molecular Life Sciences 66(22): 3575-3582

Erythropoietin modulates the structure of bone morphogenetic protein 2-engineered cranial bone. Tissue Engineering. Part A 18(19-20): 2095-2105

Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection. Proceedings of the National Academy of Sciences of the United States of America 106(5): 1602-1607

Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!. Expert Opinion on Investigational Drugs 19(10): 1179-1186

Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane Database of Systematic Reviews (): Cd007303-Cd007303

Erythropoietin or darbepoetin for patients with cancer. Cochrane Database of Systematic Reviews 12(): Cd003407-Cd003407

Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles. Plos One 4(6): E5894-E5894

Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy. Bmc Neuroscience 10(): 77-77

Erythropoietin pharmacokinetic/pharmacodynamic analysis suggests higher doses in treating neonatal anemia. Pediatrics International 51(1): 25-32

Erythropoietin pharmacology. Clinical & Translational Oncology 9(11): 715-722

Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders. Annals of Neurology 68(3): 342-352

Erythropoietin plus methylprednisolone or methylprednisolone in the treatment of acute spinal cord injury: a preliminary report. Acta Medica Iranica 52(4): 275-279

Erythropoietin possible influence on the cellular renovation processes of exocervical epithelium in norm, in case of chronic cervicitis and cervical intraepithelial neoplasia 1 and 2. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 95(2): 143-152

Erythropoietin pre-treatment prevents cognitive impairments following status epilepticus in rats. Brain Research 1282: 57-66

Erythropoietin preserves the integrity and quality of organs for transplantation after cardiac death. Shock 35(2): 126-133

Erythropoietin pretreatment suppresses seizures and prevents the increase in inflammatory mediators during pentylenetetrazole-induced generalized seizures. International Journal of Neuroscience 124(10): 762-770

Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study. Circulation Journal 74(11): 2365-2371

Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis 12(8): 1365-1375

Erythropoietin prevents cognitive impairment and oxidative parameters in Wistar rats subjected to pneumococcal meningitis. Translational Research 163(5): 503-513

Erythropoietin prevents diabetes-induced podocyte damage. Kidney & Blood Pressure Research 31(6): 411-415

Erythropoietin prevents dialysis fluid-induced apoptosis of mesothelial cells. Peritoneal Dialysis International 28(6): 648-654

Erythropoietin prevents hypoxia-induced GATA-4 ubiquitination via phosphorylation of serine 105 of GATA-4. Biological & Pharmaceutical Bulletin 36(7): 1126-1133

Erythropoietin prevents nitric oxide and cathepsin-mediated neuronal death in focal brain ischemia. Brain Research 1370: 185-193

Erythropoietin prevents oxidative stress and lipid peroxidation process in human umbilical vein endothelial cells induced by tumor necrosis factor alpha. Polski Merkuriusz Lekarski 21(126): 534-539

Erythropoietin prevents reactive oxygen species generation and renal tubular cell apoptosis at high glucose level. Biomedicine & PharmacoTherapy 64(10): 681-685

Erythropoietin prevents secondary brain injury induced by cortical lesion in mice: possible involvement of Nrf2 signaling pathway. Annals of Clinical and Laboratory Science 41(1): 25-32

Erythropoietin prevents sepsis-related acute kidney injury in rats by inhibiting NF-κB and upregulating endothelial nitric oxide synthase. American Journal of Physiology. Renal Physiology 302(8): F1045-F1054

Erythropoietin prevents vascular inflammation and oxidative stress in subtotal nephrectomized rat aorta beyond haematopoiesis. Clinical and Experimental Pharmacology & Physiology 37(12): 1139-1146

Erythropoietin prevents zinc accumulation and neuronal death after traumatic brain injury in rat hippocampus: in vitro and in vivo studies. Brain Research 1289: 96-105

Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells. Cardiovascular Research 104(1): 171-182

Erythropoietin produced in a human cell line (Dynepo) has significant differences in glycosylation compared with erythropoietins produced in CHO cell lines. Molecular Pharmaceutics 8(1): 286-296

Erythropoietin production by a hepatic adenoma in a patient with severe erythrocytosis. Acta Haematologica 121(1): 52-55

Erythropoietin production by distal nephron in normal and familial amyloidotic adult human kidneys. Clinical Nephrology 74(5): 327-335

Erythropoietin production caused by metastatic colon cancer. International Journal of Colorectal Disease 25(3): 405-405

Erythropoietin production in renal cell carcinoma and renal cysts in autosomal dominant polycystic kidney disease in a chronic dialysis patient with polycythemia: A case report. Oncology Letters 8(5): 2032-2036

Erythropoietin promotes Schwann cell migration and assembly of the provisional extracellular matrix by recruiting beta1 integrin to the cell surface. Glia 58(4): 399-409

Erythropoietin promotes axonal growth in a model of neuronal polarization. Molecular and Cellular Neurosciences 38(4): 537-547

Erythropoietin promotes axonal regeneration after optic nerve crush in vivo by inhibition of RhoA/ROCK signaling pathway. Neuropharmacology 63(6): 1182-1190

Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. Journal of Clinical Investigation 124(2): 553-563

Erythropoietin promotes deleterious cardiovascular effects and mortality risk in a rat model of chronic sports doping. Cardiovascular Toxicology 9(4): 201-210

Erythropoietin promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective analysis. Journal of Sexual Medicine 5(10): 2392-2398

Erythropoietin promotes functional recovery and enhances nerve regeneration after peripheral nerve injury in rats. Ajnr. American Journal of Neuroradiology 31(3): 509-515

Erythropoietin promotes hair shaft growth in cultured human hair follicles and modulates hair growth in mice. Journal of Dermatological Science 59(2): 86-90

Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke. Neurobiology of Disease 38(2): 259-265

Erythropoietin promotes neurological recovery after intracerebral haemorrhage in rats. International Journal of Stroke 4(4): 250-256

Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injury. Brain Research 1384: 140-150

Erythropoietin promotes proliferation of human bone marrow mesenchymal stem cells in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(6): 1392-1397

Erythropoietin promotes retinal angiogenesis in a mouse model. Molecular Medicine Reports 10(6): 2979-2984

Erythropoietin promotes spinal cord-derived neural progenitor cell proliferation by regulating cell cycle. Neuroscience 167(3): 750-757

Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis. International Journal of Oncology 40(4): 1230-1237

Erythropoietin promotes the protective properties of transplanted endothelial progenitor cells against acute lung injury via PI3K/Akt pathway. Shock 42(4): 327-336

Erythropoietin promotes the repair effect of acute kidney injury by bone-marrow mesenchymal stem cells transplantation. Experimental Biology and Medicine 238(6): 678-686

Erythropoietin protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmacology 56(6-7): 1027-1034

Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-α-induced damage. Plos One 8(1): E55291-E55291

Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain. Journal of Pathology 224(1): 101-109

Erythropoietin protects against cisplatin-induced nephrotoxicity by attenuating endoplasmic reticulum stress-induced apoptosis. Journal of Nephrology 26(1): 219-227

Erythropoietin protects against diabetes through direct effects on pancreatic beta cells. Journal of Experimental Medicine 207(13): 2831-2842

Erythropoietin protects against local anesthetic myotoxicity during continuous regional analgesia. Anesthesiology 110(3): 648-659

Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity. Infection and Immunity 82(1): 165-173

Erythropoietin protects cardiomyocytes from cell death during hypoxia/reperfusion injury through activation of survival signaling pathways. Plos One 9(9): E107453-E107453

Erythropoietin protects critically perfused flap tissue. Annals of Surgery 248(6): 919-929

Erythropoietin protects epithelial cells from excessive autophagy and apoptosis in experimental neonatal necrotizing enterocolitis. Plos One 8(7): E69620-E69620

Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production. European Journal of Cardio-Thoracic Surgery 35(5): 839-46; Discussion 846

Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis. Journal of Biological Chemistry 286(14): 12123-12132

Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha. Experimental Cell Research 315(17): 2921-2928

Erythropoietin protects neuron against ketamine induced injuries. Zhonghua Yi Xue Za Zhi 88(13): 876-879

Erythropoietin protects newborn rat against sevoflurane-induced neurotoxicity. Paediatric Anaesthesia 24(7): 749-759

Erythropoietin protects pancreatic β-cell line NIT-1 cells against cytokine-induced apoptosis via phosphatidylinositol 3-kinase/Akt signaling. Endocrine Research 36(1): 25-34

Erythropoietin protects podocytes from damage by advanced glycation end-products. Nephron. Experimental Nephrology 117(1): E21-E30

Erythropoietin protects primary cultures of rat cortical neurons from hypoxia-induced toxicity through attenuating both glutamate release and NMDA receptor evoked neurotoxicity pathway. Die Pharmazie 64(3): 210-213

Erythropoietin protects red blood cells from TRAIL1-induced cell death during red blood cell transition in Xenopus laevis. Molecular and Cellular Biochemistry 398(1-2): 73-81

Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression. Der Ophthalmologe 107(4): 347-353

Erythropoietin protects retinal pigment epithelial cells from oxidative damage. Free Radical Biology & Medicine 46(8): 1032-1041

Erythropoietin protects severe haemorrhagic shock-induced organ damage in conscious rats. Injury 41(7): 724-730

Erythropoietin protects the developing retina in an ovine model of endotoxin-induced retinal injury. Investigative Ophthalmology & Visual Science 52(5): 2656-2661

Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase. Journal of Pharmacology and Experimental Therapeutics 329(3): 900-907

Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats. Molecular Medicine 13(9-10): 509-517

Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha. Transplantation 83(10): 1371-1379

Erythropoietin provides a useful strategy for treating preoperative anemia in planned elective orthopedic surgery: an analysis of benefit in routine practice. Transfusion 52(9): 2063-2064

Erythropoietin receptor (EpoR) agonism is used to treat a wide range of disease. Molecular Medicine 19: 62-64

Erythropoietin receptor antibody inhibits oxidative stress induced retinal neovascularization in mice. International Journal of Ophthalmology 4(3): 243-246

Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer. Clinical Cancer Research 15(17): 5552-5559

Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells. Breast Cancer Research and Treatment 136(3): 739-748

Erythropoietin receptor expression in normal and neoplastic choroid plexus. Clinical Neuropathology 30(1): 33-40

Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma. Plos One 8(10): E77459-E77459

Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. Journal of Comparative Neurology 514(4): 403-414

Erythropoietin receptor in ovarian cancer cells - Letter. Molecular Cancer Therapeutics 9(4): 1070-1; Author Reply 1071

Erythropoietin receptor is detectable on peripheral blood lymphocytes and its expression increases in activated T lymphocytes. Haematologica 96(3): E12-3; Author Reply E14

Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence. Neuropathology and Applied Neurobiology 35(6): 555-565

Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Artificial Organs 34(8): 654-662

Erythropoietin receptor response circuits. Current Opinion in Hematology 17(3): 169-176

Erythropoietin receptor signaling is membrane raft dependent. Plos One 7(4): E34477-E34477

Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia. Journal of the American College of Cardiology 56(23): 1949-1958

Erythropoietin receptor signaling regulates both erythropoiesis and megakaryopoiesis in vivo. Blood Cells, Molecules & Diseases 44(1): 1-6

Erythropoietin receptor-like immunostaining on human spermatozoa. Reproductive Biomedicine Online 21(5): 718-720

Erythropoietin receptor-mediated Egr-1 activation: structural requirements and functional implications. Cellular Signalling 20(10): 1848-1854

Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and VEGF expression. In Vivo 23(5): 699-703

Erythropoietin receptors on cancer cells: a still open question. Journal of Clinical Oncology 25(13): 1812-3; Author Reply 1815

Erythropoietin receptors on tumor cells: what do they mean?. Oncologist 13 Suppl 3: 16-20

Erythropoietin reduces acute lung injury and multiple organ failure/dysfunction associated to a scald-burn inflammatory injury in the rat. Inflammation 38(1): 312-326

Erythropoietin reduces brain injury after intracerebral hemorrhagic stroke in rats. Molecular Medicine Reports 8(5): 1315-1322

Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. Cancer Biology & Therapy 6(12): 1944-1950

Erythropoietin reduces cumulative nephrotoxicity from cisplatin and enhances renal tubular cell proliferation. Prilozi 29(2): 167-183

Erythropoietin reduces ischemia-reperfusion injury after liver transplantation in rats. Transplant International 22(7): 738-746

Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner. Surgery 145(4): 372-383

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice. Brazilian Journal of Medical and Biological Research 0: 0-0

Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1β in isolated hemoperfused kidneys. European Journal of Pharmacology 660(2-3): 420-430

Erythropoietin requires endothelial nitric oxide synthase to counteract TNF-[alpha]-induced microcirculatory dysfunction in murine striated muscle. Shock 35(3): 315-321

Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease. Nefrologia 32(3): 343-352

Erythropoietin resistance as surrogate marker of graft and patient survival in renal transplantation: 3-year prospective multicenter study. Transplantation Proceedings 42(8): 2935-2937

Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction. International Journal of Cardiology 164(3): 359-364

Erythropoietin resistance index and the all-cause mortality of chronic hemodialysis patients. Blood Purification 37(2): 106-112

Erythropoietin response to anemia and its association with autonomic neuropathy in type 2 diabetic patients without advanced renal failure. Journal of Diabetes and Its Complications 24(2): 90-95

Erythropoietin responsive cardiomyogenic cells contribute to heart repair post myocardial infarction. Stem Cells 32(9): 2480-2491

Erythropoietin reverses the attentional set-shifting impairment in a rodent schizophrenia disease-like model. Psychopharmacology 212(4): 635-642

Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapy. Bmc Infectious Diseases 14(): 503-503

Erythropoietin safety concerns. Medical Letter on Drugs and Therapeutics 49(1260): 37-39

Erythropoietin signaling promotes transplanted progenitor cell survival. Faseb Journal 23(9): 3089-3099

Erythropoietin signaling: a novel regulator of white adipose tissue inflammation during diet-induced obesity. Diabetes 63(7): 2415-2431

Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation. Blood 116(26): 6072-6081

Erythropoietin stimulating agents and epoetin alfa revisited: what's really relevant?. Clinical Journal of the American Society of Nephrology 3(4): 935-937

Erythropoietin stimulating agents in the management of anemia of chronic kidney disease. Patient Preference and Adherence 2: 195-200

Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice. International Journal of Hematology 96(6): 692-700

Erythropoietin strongly protects the liver from ischemia-reperfusion injury in a pig model. Hepato-Gastroenterology 56(90): 470-475

Erythropoietin studies should not be abandoned. American Heart Journal 164(3): E5-E5

Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines. Experimental Cell Research 316(7): 1109-1118

Erythropoietin suppresses peritoneal fibrosis in rat experimental model. European Journal of Pharmacology 604(1-3): 138-149

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma. Bmc Cancer 14(): 648-648

Erythropoietin suppresses the expressions of TGF-beta1 and collagen in rat cardiac fibroblasts induced by angiotensin II. Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 636-640

Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha. Circulation 121(16): 1828-1837

Erythropoietin surprises: an immune saga. Immunity 34(1): 6-7

Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Developmental Neuroscience 31(5): 403-411

Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial. Blood 124(1): 33-41

Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis. Clinical Journal of the American Society of Nephrology 4(4): 755-762

Erythropoietin therapy for early diabetic retinopathy through its protective effects on retinal pericytes. Medical Hypotheses 76(2): 266-268

Erythropoietin therapy in a pregnant woman on maintenance hemodialysis. Saudi Journal of Kidney Diseases and Transplantation 5(4): 489-492

Erythropoietin therapy in cancer-related anaemia, yes or no?. Internal Medicine Journal 38(10): 749-750

Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clinical Journal of the American Society of Nephrology 4(4): 726-733

Erythropoietin through the placenta barrier and fetal blood-brain barrier with transient uteroplacental ischemia. Sichuan Da Xue Xue Bao. Yi Xue Ban 43(5): 687-9, 724

Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction. American Journal of Cardiology 104(8): 1035-1040

Erythropoietin to enhance protection and oxygenation after traumatic brain injury. Critical Care Medicine 41(5): 1380-1381

Erythropoietin treatment can prevent blood transfusion in infantile pyknocytosis. British Journal of Haematology 143(4): 593-595

Erythropoietin treatment enhances muscle mitochondrial capacity in humans. Frontiers in Physiology 3: 50-50

Erythropoietin treatment for ischemic cardiomyopathy: anemia correction and myocardial protection. Timely Topics in Medicine. Cardiovascular Diseases 11: E33-E33

Erythropoietin treatment for late anaemia after haemolytic disease of the newborn. Anales de Pediatria 73(6): 334-339

Erythropoietin treatment for methanol optic neuropathy. Journal of Neuro-Ophthalmology 32(4): 325-328

Erythropoietin treatment improves liver regeneration and survival in rat models of extended liver resection and living donor liver transplantation. Transplantation 86(11): 1578-1585

Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart 95(16): 1309-1314

Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES study. Journal of Nephrology 23(4): 363-368

Erythropoietin treatment in patients with myelodysplastic syndromes and type 2 diabetes. Journal of Diabetes 7(4): 493-496

Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patients. Experimental Hematology 41(2): 167-171

Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models. Journal of Endocrinology 205(1): 87-95

Erythropoietin treatment of infants with anaemia in the first three months of life. Medycyna Wieku Rozwojowego 13(4): 270-276

Erythropoietin update 2011. Medical Science Monitor 17(11): Ra240-Ra247

Erythropoietin upregulation in pulmonary arterial hypertension. Pulmonary Circulation 4(2): 269-279

Erythropoietin use and abuse. Indian Journal of Endocrinology and Metabolism 16(2): 220-227

Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: a meta-analysis. Kidney & Blood Pressure Research 35(6): 504-510

Erythropoietin use by incident hemodialysis patients in the Brazilian Unified National Health System, 2002-2003. Cadernos de Saude Publica 28(5): 856-868

Erythropoietin use in CKD patients with cancer: to tread with caution?. Journal of Nephrology 26(5): 829-835

Erythropoietin use in critically ill patients: forest and trees. Cmaj 177(7): 747-749

Erythropoietin use in extensive surgeries on liver and pancreas. Khirurgiia: 33-36

Erythropoietin use in the critically ill: current evidence. Critical Care and Resuscitation 10(3): 257-260

Erythropoietin with retrobulbar administration protects retinal ganglion cells from acute elevated intraocular pressure in rats. Journal of Ocular Pharmacology and Therapeutics 24(5): 453-459

Erythropoietin, 2,3 DPG, oxygen transport capacity, and altitude training in adolescent Alpine skiers. Aviation, Space, and Environmental Medicine 83(1): 50-53

Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair and Regeneration 22(1): 23-33

Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system. International Journal of Biological Sciences 10(8): 921-939

Erythropoietin, but not asialoerythropoietin or carbamyl-erythropoietin, attenuates monocrotaline-induced pulmonary hypertension in rats. Clinical and Experimental Hypertension 34(8): 575-581

Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology. Thescientificworldjournal 9: 1072-1104

Erythropoietin, haemoglobin, heart failure, and mortality. European Heart Journal 29(21): 2695; Author Reply 2695-6

Erythropoietin, heme oxygenase-1 and vascular tissue protective effects. Clinical Nephrology 71(3): 365-366

Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. American Journal of Kidney Diseases 52(4): 727-736

Erythropoietin, iron, or both in heart failure: FAIR-HF in perspective. European Journal of Heart Failure 12(2): 104-105

Erythropoietin, progenitor cells and restenosis. A critique of Stein et al. Thrombosis and Haemostasis 107(6): 1193; Author Reply 1194-1193; Author Reply 1194

Erythropoietin, the FDA, and oncology. New England Journal of Medicine 356(24): 2448-2451

Erythropoietin-Associated PRCA: Still an Unsolved Mystery. Journal of Immunotoxicology 3(3): 123-130

Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer. Annals of Surgical Oncology 22(7): 2329-2335

Erythropoietin-dependent endothelial proteins: potential use against erythropoietin resistance. Cytokine 51(2): 113-118

Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection. Plos One 9(3): E90942-E90942

Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2. American Journal of Physiology. Lung Cellular and Molecular Physiology 300(1): L64-L72

Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line. Molecular Cancer Research 8(4): 615-626

Erythropoietin-induced acute erythroid leukemia-like picture: a potential pitfall. Hematology/Oncology and Stem Cell Therapy 7(1): 50-52

Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke. Proceedings of the National Academy of Sciences of the United States of America 109(24): 9617-9622

Erythropoietin-induced deep vein thrombosis in myelodysplastic syndrome. Journal of the Association of Physicians of India 56: 195-196

Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin-1: exercise attenuated hypertension, oxidative stress, inflammation and immune response. Journal of Hypertension 32(4): 784-794

Erythropoietin-induced neuroprotection requires cystine glutamate exchanger activity. Brain Research 1321: 88-95

Erythropoietin-induced optimization of renal function after warm ischemia. Journal of Endourology 23(3): 359-365

Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis. Thrombosis and Haemostasis 107(4): 769-774

Erythropoietin-induced treatment costs in patients suffering from renal anemia - a comparison between biosimilar and originator drugs. Gesundheitswesen ()) 76(11): E79-E84

Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events. Transplant International 27(3): 241-248

Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways. Neuroscience 258: 218-227

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. Journal of Internal Medicine 264(5): 405-432

Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients. Cancer Science 99(8): 1656-1662

Erythropoietin-producing lung cancer. Internal Medicine 48(5): 389-390

Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. Cmaj 177(7): 725-734

Erythropoietin-receptor gene regulation in neuronal cells. Pediatric Research 65(6): 619-624

Erythropoietin-responsive sites in normal and malignant human lung tissues. Anatomical Science International 85(4): 204-213

Erythropoietin-stimulated endothelial cells support erythroid cell differentiation of CD34(+) haematopoietic progenitors. Vox Sanguinis 105(3): 253-258

Erythropoietin-stimulating agents and clinical outcomes in metastatic breast cancer patients with chemotherapy-induced anemia: a closed debate?. Tumour Biology 35(6): 5095-5100

Erythropoietin-stimulating agents in chronic kidney disease: a response to hyporesponsiveness. Seminars in Dialysis 24(5): 495-497

Erythropoietin-stimulating agents in the management of anemia of end-stage renal disease patients on regular hemodialysis: a prospective randomized comparative study from Qatar. Hemodialysis International. International Symposium on Home Hemodialysis 19(1): 33-43

Erythropoietin-stimulating agents: new data yield new insights. Oncology 21(11 Suppl Nurse Ed): 36-38

Erythropoietin-stimulating agents: ongoing concerns with safety. American Journal of Kidney Diseases 52(6): 1039-1041

Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma. Journal of Glaucoma 16(6): 567-571

Erythropoietin: a hormone with multiple functions. Pathobiology 78(1): 41-53

Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsy. Current Pharmaceutical Design 19(38): 6791-6801

Erythropoietin: a new perspective in cardiovascular therapy. Monaldi Archives for Chest Disease 70(4): 206-213

Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study. Graefe's Archive for Clinical and Experimental Ophthalmology 249(5): 731-736

Erythropoietin: a possible cytoprotective cytokine in acute necrotizing pancreatitis. Journal of Hepato-Biliary-Pancreatic Surgery 16(4): 530-537

Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE. Plos One 3(4): E1924-E1924

Erythropoietin: back to basics. Blood 115(21): 4151-4152

Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection. Pediatric Neurology 51(4): 481-488

Erythropoietin: friend and foe!. Acta Physiologica 212(2): 125-127

Erythropoietin: from the receptor to erythropoiesis stimulating agents. Nephrologie & Therapeutique 5(5 Suppl): 1-5

Erythropoietin: indications and measurement. Annales de Biologie Clinique 67(5): 505-515

Erythropoietin: new approaches to improved molecular designs and therapeutic alternatives. Current Pharmaceutical Design 14(13): 1302-1310

Erythropoietin: new directions for the nervous system. International Journal of Molecular Sciences 13(9): 11102-11129

Erythropoietin: new horizon in cardiovascular medicine. Recent Patents on Cardiovascular Drug Discovery 2(1): 5-12

Erythropoietin: not just about erythropoiesis. Lancet 375(9732): 2142-2142

Erythropoietin: physiology and molecular mechanisms. Heart Failure Reviews 13(4): 405-414

Erythropoietin: pleiotropic actions. Recenti Progressi in Medicina 101(6): 253-267

Erythropoietin: powerful protection of ischemic and post-ischemic brain. Experimental Biology and Medicine 239(11): 1461-1475

Erythropoietin: ready for prime-time cardioprotection. Trends in Pharmacological Sciences 29(5): 258-267

Erythropoietin: recent developments in the treatment of spinal cord injury. Neurology Research International 2011: 453179-453179

Erythropoietin: receptor of stimulating agents of erythropoiesis. Nephrologie & Therapeutique 4 Spec No 2: 17-22

Erythropoietin: the swinging pendulum. Leukemia Research 36(8): 939-944

Erythropoietin: will it improve outcome after subarachnoid hemorrhage?. World Neurosurgery 73(5): 463-464

Erythropoietin; a novel neuroprotective agent for ocular disorders. Journal of Ophthalmic & Vision Research 6(1): 76-77

Erythropoietin; a review on current knowledge and new concepts. Journal of Renal Injury Prevention 2(4): 119-121

Erythropoietin; bright future and new hopes for an old drug. Journal of Nephropathology 1(2): 81-82

Erythropoietinin oncologic therapy -- what so we know about the risks?. Praxis 100(20): 1239-1246

Erythropoietins from teleosts. Cellular and Molecular Life Sciences 65(22): 3545-3552

Erythropoietins in cancer patients: ESMO recommendations for use. Annals of Oncology 19 Suppl 2: Ii113-5

Erythropoietins in oncology. New England Journal of Medicine 357(12): 1262; Author Reply 1262-3

Erythropoietins should be used according to guidelines. Lancet. Oncology 9(5): 412-413

Erythrose revealed as furanose forms. Chemical Communications 49(92): 10826-8

Erythrosis pigmentosa mediofacialis: familial occurrence. Acta Dermato-Venereologica 89(2): 210-211

Erythrosis pigmentosa peribuccalis. British Journal of Dermatology and Syphilis 60(6): 203-211

Erythrosis, Or False Cyanosis. Journal of Experimental Medicine 30(3): 295-298

Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses. Journal of Medical Virology 87(1): 162-169

Erythroxylon Cuca in the Treatment of Typhus and Typhoid Fevers and of Other Febrile Diseases. British Medical Journal 1(845): 291-292

Erythræmia (Splenomegalic Polycythæmia) with a high degree of Acholuric Jaundice, probably a Manifestation of Compensatory "Hypersplenism.". Proceedings of the Royal Society of Medicine 23(2): 134-134

Erythræmia or Erythro-leukæmia. Proceedings of the Royal Society of Medicine 25(7): 964-965

Erythræmia, with Frequent Jaundice, apparently of Hæmolytic Nature. Slow Recovery from Extremely Severe Hæmatemesis. Proceedings of the Royal Society of Medicine 25(1): 16-17

Erytrocyte membrane change due to the chemical treatment studied with atomic force microscopy. Przeglad Lekarski 66(12): 1031-1035

Erzeugung Von Bosartigen Tumoren Durch Einspritzen Von Milzbrei Und Blut Von Tumortragenden Ratten Und Mausen. Annals of Surgery 93(1): 74-76

Es kann die Spur von unseren Erdetagen--on pharmacologists and pharmacology. Naunyn-Schmiedeberg's Archives of Pharmacology 380(5): 465-471

Es&T books. Environmental Science & Technology 28(6): 294a-294a

Es&T inquiry express. Environmental Science & Technology 28(9): 404a-404a

Es-x/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes. Biochimica et Biophysica Acta 1791(12): 1133-1143

EsDREB2B, a novel truncated DREB2-type transcription factor in the desert legume Eremosparton songoricum, enhances tolerance to multiple abiotic stresses in yeast and transgenic tobacco. Bmc Plant Biology 14(): 44-44

EsKiMo - the nutrition module in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 50(5-6): 902-908

EsRAGE. Nihon Rinsho. Japanese Journal of Clinical Medicine 64 Suppl 9: 300-304

EsaD, a secretion factor for the Ess pathway in Staphylococcus aureus. Journal of Bacteriology 193(7): 1583-1589

Esaias Tegner and his physicians. Lakartidningen 105(14): 1033-1035

Esaki diodes live and learn. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences 86(4): 451-453

Esaliency (extended saliency): meaningful attention using stochastic image modeling. IEEE Transactions on Pattern Analysis and Machine Intelligence 32(4): 693-708

Esberiven Fort-associated lymphocytic colitis. Gastroenterologie Clinique et Biologique 32(8-9): 697-698

Esc2 and Sgs1 act in functionally distinct branches of the homologous recombination repair pathway in Saccharomyces cerevisiae. Molecular Biology of the Cell 20(6): 1683-1694

EscI: a crucial component of the type III secretion system forms the inner rod structure in enteropathogenic Escherichia coli. Biochemical Journal 442(1): 119-125

EscO, a functional and structural analog of the flagellar FliJ protein, is a positive regulator of EscN ATPase activity of the enteropathogenic Escherichia coli injectisome. Journal of Bacteriology 196(12): 2227-2241

Esca and Black Dead Arm: two major actors of grapevine trunk diseases. Comptes Rendus Biologies 332(9): 765-783

Escabiosis. Revista Espanola de Sanidad Penitenciaria 11(2): 64-65

Escalate shamefully, de-escalate angrily or gratefully: the influence of discrete emotions on escalation of commitment. Scandinavian Journal of Psychology 55(4): 380-388

Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma. Przeglad Lekarski 69(5): 171-175

Escalated BEACOPP in advanced Hodgkin's lymphoma. Lancet 379(9828): 1767-1768

Escalated handling of young C57BL/6 mice results in altered Morris water maze performance. Upsala Journal of Medical Sciences 119(1): 1-9

Escalated hyperfractionated accelerated radiation therapy combined with chemotherapy for stage IIIB non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 5(6): 420-422

Escalated or suppressed cocaine reward, tegmental BDNF, and accumbal dopamine caused by episodic versus continuous social stress in rats. Journal of Neuroscience 31(27): 9848-9857

Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic fluid mesenchymal stem cells and fermented soybean extracts, Natto. Journal of Biomedical Science 16: 75-75

Escalated regimen of hepatitis B vaccine in childhood hematological malignancies while on chemotherapy. Southeast Asian Journal of Tropical Medicine and Public Health 41(3): 555-561

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. Journal of Clinical Oncology 27(27): 4548-4554

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet. Oncology 15(4): 464-473

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet. Oncology 8(6): 475-487

Escalating antihypertensive medications in end-stage renal disease patients does not improve blood pressure control. Journal of Clinical Hypertension 10(3): 215-218

Escalating burden of breast cancer in southern Thailand: analysis of 1990-2010 incidence and prediction of future trends. Cancer Epidemiology 38(3): 235-243

Escalating chronic kidney diseases of multi-factorial origin in Sri Lanka: causes, solutions, and recommendations. Environmental Health and Preventive Medicine 19(6): 375-394

Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasms. Hpb 12(2): 115-122

Escalating coronary heart disease and risk factors in South Asians. Indian Heart Journal 59(3): 214-217

Escalating criminal and civil violations: pharma has corporate integrity? Not really. Bmj 347: F7507-F7507

Escalating dose indomethacin for prophylactic closure of patent ductus arteriosus does not improve closure rates and is associated with increased complications. Journal of Pediatrics 154(1): 153-153

Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema. Journal of Allergy and Clinical Immunology. in Practice 2(1): 77-84

Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving. Journal of Clinical Psychopharmacology 33(5): 667-674

Escalating energy costs threaten health care for critically ill and homebound seniors: home care nurses, aides and therapists drive 4.8 billion miles per year to reach shut-in patients. Caring 27(8): 44-47

Escalating immunotherapy of multiple sclerosis. Therapeutic Advances in Neurological Disorders 1(3): 181-192

Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. Journal of Allergy and Clinical Immunology 128(6): 1349-1350.E5

Escalating medication shortages: a public health and patient care crisis. Missouri Medicine 109(1): 20-23

Escalating methylisothiazolinone/methylchloroisothiazolinone allergy probably attributable to methylisothiazolinone in leave-on body cosmetics. Contact Dermatitis 70(5): 316-317

Escalating obesity rates pose health, budget threats. JAMA 308(15): 1514-1514

Escalating regulation of 5T4-specific IFN-γ<sup>+</sup> CD4<sup>+</sup> T cells distinguishes colorectal cancer patients from healthy controls and provides a target for <i>in vivo</i> therapy. Cancer Immunology Research 1(6): -

Escalating slant: increasing physiological potential does not reduce slant overestimates. Psychological Science 22(2): 209-211

Escalating the global fight against neglected tropical diseases through interventions in the Asia Pacific region. Advances in Parasitology 72: 31-53

Escalating the pathway from the associate's degree in nursing to the bachelor of science in nursing and/or the master of science in nursing: what is standing in the way?. North Carolina Medical Journal 72(4): 300-303

Escalating therapy of cutaneous side effects of EGFR inhibitors: experience of German reference centers. Journal der Deutschen Dermatologischen Gesellschaft 10(8): 559-563

Escalating threat of wheat rusts. Science 329(5990): 369-369

Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas. Pediatric Hematology and Oncology 30(4): 263-272

Escalating violence in PG-13 movies. Pediatrics 134(5): 1024-1025

Escalating water demand for energy production and the potential for use of treated municipal wastewater. Environmental Science & Technology 45(10): 4195-4200

Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I study. Investigational New Drugs 29(4): 680-687

Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement. Clinical Oncology ) 21(4): 343-360

Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity. Sexually Transmitted Infections 84(5): 352-355

Escalation of aggressive vocal signals: a sequential playback study. Proceedings. Biological Sciences 280(1768): 20131553-20131553

Escalation of care and failure to rescue: a multicenter, multiprofessional qualitative study. Surgery 155(6): 989-994

Escalation of cocaine intake and incubation of cocaine seeking are correlated with dissociable neuronal processes in different accumbens subregions. Biological Psychiatry 76(1): 31-39

Escalation of drug self-administration as a hallmark of persistent addiction liability. Behavioural Pharmacology 24(5-6): 356-362

Escalation of glaucoma therapy after deep lamellar endothelial keratoplasty. Cornea 29(9): 991-995

Escalation of methamphetamine-related crime and fatalities in the Dresden region, Germany, between 2005 and 2011. Forensic Science International 233(1-3): 51-54

Escalation of socioeconomic disparities among patients with colorectal cancer receiving advanced surgical treatment. Annals of Surgical Oncology 22(5): 1746-1750

Escalation patterns of varying periods of heroin access. Pharmacology, Biochemistry, and Behavior 98(4): 570-574

Escalation regimen of cilostazol for acute brain infarction. Internal Medicine 50(15): 1559-1563

Escalation research: providing new frontiers for applying behavior analysis to organizational behavior. Behavior Analyst 23(2): 203-218

Escalation strategies for combination therapy Phase I trials. Pharmaceutical Statistics 11(3): 258-266

Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myeloma. Leukemia & Lymphoma 48(12): 2345-2351

Escalation to Major Depressive Disorder among adolescents with subthreshold depressive symptoms: evidence of distinct subgroups at risk. Journal of Affective Disorders 158(): 133-138

Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis. Alimentary Pharmacology & Therapeutics 40(5): 486-497

Escalation with overdose control for phase I drug-combination trials. Statistics in Medicine 32(25): 4400-4412

Escalation with overdose control using all toxicities and time to event toxicity data in cancer Phase I clinical trials. Contemporary Clinical Trials 37(2): 322-332

Escalation with overdose control using time to toxicity for cancer phase I clinical trials. Plos One 9(3): E93070-E93070

Escalations. Science 257(5066): 110-111

Escalator-related injuries. Mmw Fortschritte der Medizin 150(14): 38-40

Escalators, rubber clogs, and severe foot injuries in children. Journal of Pediatric Orthopedics 30(5): 414-419

Escape Of The Ventricle, In Association With Cerebro-Spinal Fever. British Medical Journal 2(2861): 640-640

Escape and avoidance learning in the earthworm Eisenia hortensis. Peerj 2: E250-E250

Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study. Clinical Endocrinology 81(6): 883-890

Escape and survival of Corophium volutator and Ilyanassa obsoleta exposed to freshwater and chlorothalonil. Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering 44(8): 778-790

Escape as reinforcement and escape extinction in the treatment of feeding problems. Journal of Applied Behavior Analysis 44(4): 719-735

Escape behavior of quantum two-particle systems with Coulomb interactions. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics 83(2 Pt 2): 026208-026208

Escape behaviour elicited by a visual stimulus. A comparison between lateralised and non-lateralised female topminnows. Laterality 14(3): 300-314

Escape behaviour: reciprocal inhibition ensures effective escape trajectory. Current Biology 19(16): R697-R699

Escape circuits built in teleost hindbrain segments. Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme 53(4 Suppl): 506-511

Escape driven by alpha-stable white noises. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics 75(2 Pt 1): 021109-021109

Escape dynamics of coupled particles in nonlinear, disordered lattices. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics 80(5 Pt 1): 051109-051109

Escape faulty thinking: how to minimize the influence of bias in patient assessment. Jems 33(11): 116-8, 120, 122 Passim

Escape from Adaptive Conflict follows from weak functional trade-offs and mutational robustness. Proceedings of the National Academy of Sciences of the United States of America 109(37): 14888-14893

Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers. Journal of Immunology 188(7): 3364-3370

Escape from CD8+ T cell response by natural variants of an immunodominant epitope from Theileria parva is predominantly due to loss of TCR recognition. Journal of Immunology 187(11): 5910-5920

Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs. Journal of Virology 82(23): 11803-11812

Escape from X chromosome inactivation is an intrinsic property of the Jarid1c locus. Proceedings of the National Academy of Sciences of the United States of America 105(44): 17055-17060

Escape from X inactivation in mice and humans. Genome Biology 11(6): 213-213

Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope. Journal of Virology 86(2): 991-1000

Escape from a submersible vehicle simulator wearing different thermoprotective flotation clothing. Aviation, Space, and Environmental Medicine 84(7): 708-715

Escape from attracting sets in randomly perturbed systems. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics 82(4 Pt 2): 046217-046217

Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity. Virology 397(1): 224-230

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. Plos Pathogens 5(9): E1000594-E1000594

Escape from cavity through narrow tunnel. Journal of Chemical Physics 130(24): 245104-245104

Escape from competition: neighbors reduce Centaurea stoebe performance at home but not away. Ecology 92(12): 2208-2213

Escape from disability (on advanced directives and end-of-life care). South Dakota Medicine 61(4): 142-142

Escape from extreme specialization: passionflowers, bats and the sword-billed hummingbird. Proceedings. Biological Sciences 281(1795): -

Escape from flatland: increasing saturation as an approach to improving clinical success. Journal of Medicinal Chemistry 52(21): 6752-6756

Escape from floral herbivory by early flowering in Arabidopsis halleri subsp. gemmifera. Oecologia 164(3): 713-720

Escape from growth restriction in small colony variants of Salmonella typhimurium by gene amplification and mutation. Molecular Microbiology 79(2): 305-315

Escape from harm: linking affective vision and motor responses during active avoidance. Social Cognitive and Affective Neuroscience 9(12): 1993-2000

Escape from homeostasis. Mathematical Biosciences 257: 104-110

Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Molecular Cancer Therapeutics 8(10): 2959-2968

Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors. Viruses 4(12): 3859-3911

Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. Journal of Infectious Diseases 201(6): 946-955

Escape from lysosomes. Nature: New Biology 233(42): 223-223